Visual field defects

H7_VISFIELDDEF

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53.4 Hospital discharge: ICD-9 — 3684 Cause of death: ICD-10 — H53.4 Cause of death: ICD-9 — 3684 2 out of 7 registries used, show all original rules.	3950
4. Check minimum number of events None	3950
5. Include endpoints None	3950
6. Filter based on genotype QC (FinnGen only)	3545

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53
Name in latin: Defectus campi visualis

NAME	H7_VISFIELDDEF
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H534
HD_ICD_9	3684
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H534
COD_ICD_9	3684
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Visual field defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23456	11336	11957
Only index persons	21057	10440	10617
Unadjusted period prevalence (%)
Whole population	0.33	0.32	0.33
Only index persons	0.39	0.38	0.41
Median age at first event (years)
Whole population	61.46	60.49	62.29
Only index persons	60.42	59.50	61.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3545	1825	1720
Unadjusted period prevalence (%)	0.72	0.65	0.79
Median age at first event (years)	62.08	58.63	65.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3662: Matched controls
36620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.5

308.5

688

1485

AA1AD

NOMESCO Finland

CT of head and brain

4.0

307.7

1876

7566

H53.4

ICD-10 Finland

Visual field defects

190121.6

307.7

3637

H53.1

ICD-10 Finland

Subjective visual disturbances

15.1

307.7

568

439

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

6.5

307.7

1117

2301

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

8.0

307.7

990

1629

XCK00

NOMESCO Finland

Perimetry

15.1

307.7

1104

1020

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.9

307.7

1372

4004

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

31.3

307.7

218

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

8.2

286.5

404

546

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

7.0

265.2

434

691

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

7.7

253.1

375

535

H47.2

ICD-10 Finland

Optic atrophy

62.1

227.2

126

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

49.9

224.7

130

H53.2

ICD-10 Finland

Diplopia

21.8

221.0

165

CS494

NOMESCO Finland

Other visual field testing

8.4

220.3

299

384

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

17.4

219.2

182

110

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.9

204.4

722

2191

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.4

202.2

305

442

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

16.3

199.4

171

110

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.3

197.7

427

882

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.8

185.4

653

1969

N03AX14

ATC

levetiracetam; systemic

7.3

184.9

281

410

XA800

NOMESCO Finland

Neuropsychological investigation

6.0

183.6

347

633

E23.00

ICD-10 Finland

Panhypopituitarism

34.2

182.5

116

H53.9

ICD-10 Finland

Visual disturbance, unspecified

8.6

181.9

240

297

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

8.8

177.2

229

276

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.9

177.1

596

1738

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

12.6

172.2

171

142

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

60.3

168.5

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

8.4

165.8

223

282

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

8.4

157.4

210

263

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.2

150.5

439

1149

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

14.6

148.0

134

K90

ICPC

Stroke/cerebrovascular accident

5.7

144.0

279

519

H02AB09

ATC

hydrocortisone; systemic

7.0

139.4

219

330

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.0

139.1

428

1163

H46

ICD-10 Finland

Optic neuritis

18.9

138.8

110

B01AC04

ATC

clopidogrel; oral

2.7

135.7

929

4079

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

12.9

130.4

127

102

101

Kela drug reimbursment

Anterior pituitary hypofunction

15.2

123.2

109

N03AF02

ATC

oxcarbazepine; oral

5.3

114.7

242

485

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.3

114.0

481

1604

N03AX18

ATC

lacosamide; systemic

15.4

106.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.9

105.7

241

516

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.0

104.9

323

873

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

8.0

104.9

144

186

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

5.5

104.1

207

393

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

6.9

103.8

164

248

XCD10

NOMESCO Finland

Electrophysiological examination of eye

5.9

101.6

189

337

R51.80

ICD-10 Finland

Headache

2.6

100.4

710

3120

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.4

100.2

268

652

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

16.6

98.7

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.4

95.0

249

596

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

90.5

951

4956

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.7

85.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

84.1

1989

13834

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

7.4

83.5

123

172

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

25.6

83.1

183

Kela drug reimbursment

Lamotrigin and topiramate

12.1

82.5

102

Kela drug reimbursment

Diabetes insipidus

27.1

81.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

77.6

279

835

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

77.0

488

2015

R4120

NOMESCO Finland

Occupational therapy

3.1

75.8

352

1231

B01AA03

ATC

warfarin; systemic

2.1

75.3

915

4999

N05BA09

ATC

clobazam; oral

17.0

74.7

N03AG01

ATC

valproic acid; systemic, rectal

3.3

74.2

305

992

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

6.1

72.6

127

213

PA6AD

NOMESCO Finland

CT of neck arteries

3.9

71.1

218

585

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

12.5

71.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

71.0

799

4229

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

8.3

70.6

114

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

10.9

68.8

H53.0

ICD-10 Finland

Amblyopia ex anopsia

26.4

68.1

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.1

68.0

120

203

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.2

67.5

292

978

N18

ICPC

Paralysis/weakness

4.9

66.8

150

316

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

10.2

65.6

K91

ICPC

Cerebrovascular disease

5.8

63.6

117

206

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

63.1

713

3760

Z2445

NOMESCO Finland

Psychologist

3.9

62.9

194

522

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.2

62.9

H34.2

ICD-10 Finland

Other retinal artery occlusions

10.8

61.1

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.8

61.0

332

1263

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

60.7

387

1595

I63.8

ICD-10 Finland

Other cerebral infarction

7.2

60.6

130

R42

ICD-10 Finland

Dizziness and giddiness

1.9

60.5

968

5764

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

8.4

60.4

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

7.6

60.2

116

H54.7

ICD-10 Finland

Unspecified visual loss

13.9

59.6

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

7.7

59.4

112

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.3

59.3

155

369

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

58.9

348

1380

N03AB02

ATC

phenytoin; systemic

6.6

58.3

145

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

57.7

396

1689

L01AX03

ATC

temozolomide; systemic

9.0

57.6

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

6.7

57.3

138

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

9.5

56.3

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.9

55.7

126

267

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

23.2

53.7

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

8.4

53.5

H47.1

ICD-10 Finland

Papilloedema, unspecified

10.1

53.1

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.3

52.3

107

208

ZXA10

NOMESCO Finland

Bilateral

1.9

51.5

756

4344

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

5.6

51.1

176

G35

ICD-10 Finland

Multiple sclerosis

6.1

50.9

149

C10AA05

ATC

atorvastatin; oral

1.7

50.1

1657

12053

F05

ICPC

Visual disturbance other

3.6

49.9

167

475

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.9

48.8

145

380

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

16.6

48.7

TAB00

NOMESCO Finland

Lumbar puncture

3.1

48.7

209

695

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.5

48.6

119

269

H40.11

ICD-10 Finland

Low pressure glaucoma

4.0

47.8

138

354

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

13.9

47.6

G45.3

ICD-10 Finland

Amaurosis fugax

4.7

47.0

109

236

ZXC95

NOMESCO Finland

Use of surgical navigator

5.8

46.9

151

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

46.5

625

3475

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.5

46.1

114

260

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.9

45.1

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

44.9

138

370

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.1

44.8

130

N03AX09

ATC

lamotrigine; oral

3.1

44.1

190

633

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

9.0

43.7

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.2

43.6

180

B01AC07

ATC

dipyridamole; systemic

2.8

43.5

233

876

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

4.6

43.0

103

229

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

5.9

42.6

130

ZXD05

NOMESCO Finland

Urgent procedure

1.7

42.4

1124

7632

Z3231

NOMESCO Finland

Registered nurse

1.7

41.7

1030

6858

N03AF01

ATC

carbamazepine; oral, rectal

2.7

41.2

234

906

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.8

39.0

I63

ICD-10 Finland

Cerebral infarction

6.5

38.8

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

8.2

38.5

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

4.7

38.3

193

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

37.6

619

3655

XCH00

NOMESCO Finland

Eye pressure measurement

2.6

37.5

224

889

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.5

36.9

134

D35.30

ICD-10 Finland

Craniopharyngoma

360.8

36.0

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

7.3

36.0

109

Kela drug reimbursment

Multiple sclerosis

6.2

35.7

100

G40.10

ICD-10 Finland

Simple partial seizures

7.2

35.2

C03CA01

ATC

furosemide; systemic

1.6

34.6

1229

8874

H47.3

ICD-10 Finland

Other disorders of optic disc

10.1

34.5

R47.0

ICD-10 Finland

Dysphasia and aphasia

5.2

34.2

140

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

13.4

34.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

33.8

905

6098

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

33.7

125

380

A28

ICPC

Limited function/disability NOS

1.7

33.7

758

4879

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

33.6

307

1471

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

33.6

928

6301

H01AC01

ATC

somatropin; parenteral

11.8

33.4

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.8

33.1

171

630

WX892

NOMESCO Finland

Monitored bed care

2.1

32.9

320

1571

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.3

32.8

124

382

C10AA01

ATC

simvastatin; oral

1.5

32.7

1570

12075

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.0

32.4

229

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

32.3

1530

11724

AAF00

NOMESCO Finland

Ventriculostomy

6.9

31.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

31.7

875

5925

N06AX11

ATC

mirtazapine; oral

1.6

31.7

1200

8751

ZXC86

NOMESCO Finland

Use of endoscopic device

7.7

31.4

N19

ICPC

Speech disorder

4.3

31.3

196

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

31.0

826

5542

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

4.2

30.9

202

N29

ICPC

Neurological sympt/complt other

3.6

30.8

102

288

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

6.7

30.6

N03AX11

ATC

topiramate; oral

3.6

30.5

102

290

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.4

30.5

C07AB07

ATC

bisoprolol; oral

1.5

30.5

1816

14533

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.0

30.5

135

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.7

30.2

264

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

30.0

352

1852

114

Kela drug reimbursment

Glaucoma

2.0

29.9

374

2011

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

29.9

513

3052

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

29.8

818

5521

R53

ICD-10 Finland

Malaise and fatigue

1.6

29.7

921

6397

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

7.2

29.7

PA2AD

NOMESCO Finland

CT angiography of brain

5.5

29.6

105

Z2446

NOMESCO Finland

Social worker

2.2

29.4

250

1163

315

Kela drug reimbursment

Clopidogrel

4.7

29.2

144

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

5.0

29.1

125

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

7.5

28.9

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

9.1

28.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

28.6

710

4669

G40.89

ICD-10 Finland

Other epilepsy

7.9

28.5

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

28.3

1064

7705

H53.8

ICD-10 Finland

Other visual disturbances

5.2

28.3

113

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

28.1

1230

9195

M03BX01

ATC

baclofen; systemic

3.6

27.6

261

WX872

NOMESCO Finland

Intensive care

2.3

27.6

217

976

C09AA05

ATC

ramipril; oral

1.6

27.3

942

6687

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

9.5

27.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

26.9

1242

9372

H40.0

ICD-10 Finland

Glaucoma suspect

2.0

26.6

318

1682

L28

ICPC

Limited function/disability (L)

1.6

26.5

741

5007

R50.9

ICD-10 Finland

Fever, unspecified

1.7

26.4

554

3478

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

26.4

496

3023

G40

ICD-10 Finland

Epilepsy

5.6

26.3

N02BE01

ATC

paracetamol; systemic, rectal

1.7

26.2

3185

29127

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

25.9

26.1

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

25.9

250

1222

SPAT1229

SPAT

Assessment of need for aid

2.0

25.8

308

1628

G44.2

ICD-10 Finland

Tension-type headache

1.8

25.8

451

2691

H02AB06

ATC

prednisolone; systemic

1.4

25.7

1667

13397

N03AX12

ATC

[U] gabapentin; oral

1.7

25.2

563

3593

R06.0

ICD-10 Finland

Dyspnoea

1.5

24.6

989

7227

A02BC02

ATC

pantoprazole; systemic

1.5

24.5

2405

20793

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

24.4

434

2600

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

24.4

1138

8566

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

24.2

231

1124

N03AG04

ATC

vigabatrin; oral

56.4

24.0

H34.1

ICD-10 Finland

Central retinal artery occlusion

6.3

24.0

N06AB04

ATC

citalopram; systemic

1.6

24.0

696

4732

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

37.8

23.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

23.7

456

2793

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

23.6

595

3908

XF404

NOMESCO Finland

Ambulatory ECG

1.9

23.6

326

1809

C07AB02

ATC

metoprolol; systemic

1.6

23.4

742

5141

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.3

23.4

141

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

4.7

23.3

113

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

7.3

23.3

S01EE01

ATC

latanoprost; ophthalmic

2.0

23.3

263

1362

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.7

23.3

126

476

N88

ICPC

Epilepsy

6.1

23.3

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

23.3

190

869

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

9.1

23.0

3684A

ICD-9 Finland

Visual disturbances, Visual field defects[HOMONYYMIT NÄKÖKENTTÄPUUTOKSET]

+∞

22.9

181

Kela drug reimbursment

Retigabine and vigabatrin

84.0

22.7

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

22.6

575

3783

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

22.6

403

2415

N28

ICPC

Limited function/disability (N)

3.2

22.5

277

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

22.5

2222

19069

H03AA01

ATC

levothyroxine sodium; systemic

1.5

22.5

767

5397

G43.3

ICD-10 Finland

Complicated migraine

3.8

22.5

181

S01ED51

ATC

timolol, combinations; ophthalmic

1.9

22.4

305

1683

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.6

22.3

210

G91.0

ICD-10 Finland

Communicating hydrocephalus

6.3

22.3

Z3226

NOMESCO Finland

Physiotherapist

1.6

22.1

628

4241

H26.4

ICD-10 Finland

After-cataract

1.8

22.0

390

2331

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

22.0

416

2534

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

8.5

21.9

207

Kela drug reimbursment

Chronic arrhythmias

1.6

21.8

615

4142

H54.4

ICD-10 Finland

Blindness, monocular

29.2

21.8

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

80.6

21.7

SPAT1216

SPAT

Assessment of functional ability

1.6

21.3

571

3799

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

7.6

21.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

21.0

121

472

XCW10

NOMESCO Finland

Assessment of vision

3.3

21.0

238

WX882

NOMESCO Finland

High dependency care

2.7

21.0

117

449

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.2

21.0

136

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

21.0

183

860

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

20.8

637

4370

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

20.7

1174

9106

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.7

20.7

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.3

20.6

121

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

20.6

414

2562

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

20.5

968

7254

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

8.2

20.5

ZXY02

NOMESCO Finland

Neuropsychologist

6.5

20.5

N03AE01

ATC

clonazepam; systemic

2.1

20.3

200

985

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

20.2

393

2409

S06.0

ICD-10 Finland

Concussion

1.7

20.1

368

2219

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

20.0

630

4344

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.8

20.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

19.9

548

3664

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.5

19.9

125

509

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

19.9

381

2326

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

19.8

1168

9103

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

19.7

563

3799

A02BC01

ATC

omeprazole; systemic

1.5

19.7

925

6919

I50.0

ICD-10 Finland

Congestive heart failure

1.8

19.5

309

1787

SPAT1260

SPAT

Consultation of another employee

1.6

19.2

583

3985

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

16.8

19.1

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.7

19.1

164

R1260

NOMESCO Finland

Evaluation of communicative skills

3.2

19.1

237

R55

ICD-10 Finland

Syncope and collapse

1.7

19.0

404

2536

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

6.2

18.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

18.9

838

6191

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

5.8

18.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

18.8

964

7316

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

8.1

18.8

R4110

NOMESCO Finland

Physiotherapy

1.4

18.8

943

7131

301

Kela drug reimbursment

Growth hormone

23.8

18.6

H50.1

ICD-10 Finland

Divergent concomitant strabismus

6.1

18.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

18.5

1455

11865

E23.2

ICD-10 Finland

Diabetes insipidus

14.2

18.5

ZXE00

NOMESCO Finland

One hour or less

1.4

18.5

1272

10148

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

5.4

18.5

SPAT1254

SPAT

Administration of medicine

1.6

18.4

518

3478

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.3

18.4

138

609

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

6.4

18.4

ZXA05

NOMESCO Finland

Left side

1.5

18.3

826

6116

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.8

18.3

346

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.6

18.3

169

N01

ICPC

Headache

1.7

18.3

333

2002

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.0

18.3

H52.1

ICD-10 Finland

Myopia

2.5

18.2

116

476

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

19.4

18.2

H35.6

ICD-10 Finland

Retinal haemorrhage

5.2

18.1

B01AB05

ATC

enoxaparin; parenteral

1.4

18.1

1065

8270

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

14.4

18.1

CKD40

NOMESCO Finland

Endophotocoagulation of retina

3.3

18.0

205

XCH05

NOMESCO Finland

Eye pressure longterm registration

4.1

18.0

121

H54.1

ICD-10 Finland

Severe visual impairment, binocular

52.8

17.9

G50.1

ICD-10 Finland

Atypical facial pain

3.2

17.8

217

C08CA01

ATC

amlodipine; oral

1.4

17.7

1362

11046

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

6.6

17.5

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.7

17.5

338

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

17.4

574

7999

WX140

NOMESCO Finland

Parabulbar anesthesy

2.1

17.4

178

890

N05CF01

ATC

zopiclone; oral

1.4

17.4

1080

8455

J01DB01

ATC

cefalexin; oral

1.4

17.4

2828

25778

N03AX16

ATC

[U] pregabalin

1.5

17.3

745

5463

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

17.2

296

G91.1

ICD-10 Finland

Obstructive hydrocephalus

6.2

17.2

C10AX09

ATC

ezetimibe; oral

1.5

17.2

582

4066

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

17.1

343

2116

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

17.1

565

3925

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.8

17.0

140

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

17.0

992

7680

XF620

NOMESCO Finland

Examination of circulation with color method

5.9

17.0

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

7.5

17.0

ZXC40

NOMESCO Finland

Use of ultrasound

5.0

16.9

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

16.8

377

2394

W19

ICD-10 Finland

Unspecified fall

1.7

16.7

341

2114

B01AF02

ATC

apixaban; oral

1.5

16.7

496

3368

S01EC04

ATC

brinzolamide; ophthalmic

2.1

16.7

164

808

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.7

16.6

142

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

16.6

372

2362

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

16.6

206

1102

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

16.6

575

4035

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

6.7

16.6

280

Kela drug reimbursment

Clopidogrel

3.1

16.5

232

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

16.5

899

6872

N17

ICPC

Vertigo/dizziness

1.6

16.5

447

2973

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

16.4

170

854

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

16.4

214

1165

S01EA05

ATC

brimonidine; ophthalmic

2.5

16.3

103

421

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

16.2

291

1744

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

6.8

16.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.1

797

5987

L04AA06

ATC

mycophenolic acid; systemic

2.9

16.0

258

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

3.6

15.9

142

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.9

15.7

WX402

NOMESCO Finland

General anaesthesia

1.4

15.7

713

5270

M79.6

ICD-10 Finland

Pain in limb

1.3

15.7

1423

11779

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

15.6

146

706

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

11.7

15.5

R11

ICD-10 Finland

Nausea and vomiting

1.7

15.5

295

1795

R02

ICPC

Shortness of breath/dyspnoea

1.5

15.5

459

3112

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

15.5

499

3445

A46

ICD-10 Finland

Erysipelas

1.5

15.5

512

3554

R4130

NOMESCO Finland

Speech therapy

2.4

15.5

103

432

N86

ICPC

Multiple sclerosis

5.4

15.4

H50.0

ICD-10 Finland

Convergent concomitant strabismus

5.8

15.4

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

15.4

316

1963

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

5.2

15.3

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

15.2

1297

10619

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

5.5

15.2

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

15.2

1226

9958

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.9

922

7178

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

14.9

236

1363

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.9

1137

9153

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.8

2343

20924

AN1

Coronary angiography

1.6

14.8

392

2592

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

14.7

598

4322

K89

ICPC

Transient cerebral ischaemia

3.5

14.7

145

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.3

14.6

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

5.3

14.6

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

14.6

162

834

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.0

14.6

104

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

14.5

168

878

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

14.5

627

4585

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

14.5

450

3081

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

14.4

255

1521

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

14.4

138

674

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

14.4

207

1162

SPAT1263

SPAT

Sampling

1.3

14.4

1337

11066

N05BA01

ATC

diazepam; systemic, rectal

1.5

14.3

411

2765

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

14.3

1414

11801

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

14.3

161

834

S18

ICPC

Laceration/cut

1.3

14.2

1586

13461

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

14.2

235

1376

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

14.1

873

6787

SPAT1301

SPAT

No procedures

1.4

14.1

1013

8062

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

14.1

304

1911

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.0

960

7584

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.9

13.9

177

956

J01FF01

ATC

clindamycin; systemic

1.4

13.9

854

6634

L03AB07

ATC

interferon beta-1a; parenteral

5.6

13.8

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

17.6

13.8

C03DA01

ATC

spironolactone; oral

1.5

13.8

433

2971

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.6

13.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

13.7

149

762

N06AB10

ATC

escitalopram; oral

1.4

13.7

583

4247

Z2221

NOMESCO Finland

Medical doctor

1.4

13.7

856

6664

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

6.5

13.6

N04BC06

ATC

cabergoline; oral

5.1

13.6

H53

ICD-10 Finland

Visual disturbances

4.2

13.6

WX704

NOMESCO Finland

Intubation

1.7

13.6

269

1654

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.6

410

2789

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

14.7

13.6

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

13.4

363

2410

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

6.1

13.4

G93.2

ICD-10 Finland

Benign intracranial hypertension

18.3

13.4

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

18.3

13.4

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.4

13.3

374

R51

ICD-10 Finland

Headache

1.9

13.3

160

847

R04.0

ICD-10 Finland

Epistaxis

1.7

13.3

266

1639

G81.1

ICD-10 Finland

Spastic hemiplegia

21.2

13.3

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.5

13.3

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

13.8

13.2

H57.1

ICD-10 Finland

Ocular pain

2.1

13.2

121

582

H33.5

ICD-10 Finland

Other retinal detachments

4.0

13.1

N05BA04

ATC

oxazepam; oral

1.4

13.0

825

6427

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

13.0

317

2052

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

13.0

190

1072

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

16.8

13.0

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.6

13.0

118

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

12.9

457

3209

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

28.5

12.9

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.3

12.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

12.9

212

1238

E22.1

ICD-10 Finland

Hyperprolactinaemia

4.4

12.9

K78

ICPC

Atrial fibrillation/flutter

1.6

12.8

286

1812

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

12.8

387

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

4.9

12.8

H50.31

ICD-10 Finland

Intermittent exotropia

4.7

12.8

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.8

1059

8587

205

Kela drug reimbursment

Chronic hypertension

1.3

12.7

932

7422

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.5

12.6

125

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

70.1

12.6

C09CA06

ATC

candesartan; oral

1.4

12.6

762

5893

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

12.5

128

642

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.5

1352

11369

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

12.4

156

839

N05AH04

ATC

quetiapine; oral

1.4

12.4

525

3817

WX002

NOMESCO Finland

Sedation and analgesia

1.4

12.4

618

4626

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.4

12.4

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

12.3

635

4778

A06AD11

ATC

lactulose; oral

1.4

12.3

509

3683

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

12.3

173

Angiography of the heart and coronary arteries

1.7

12.1

221

1329

A03

ICPC

Fever

1.4

12.1

491

3539

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

5.5

12.1

N06AX21

ATC

duloxetine; oral

1.5

12.1

353

2381

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

12.1

429

3015

J01MA02

ATC

ciprofloxacin; systemic

1.3

12.0

1279

10712

N03AX22

ATC

perampanel; oral

18.1

12.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

12.0

167

928

C09CA01

ATC

losartan; oral

1.3

12.0

853

6753

N05CD08

ATC

midazolam; nasal, systemic

2.3

12.0

374

C01DA14

ATC

isosorbide mononitrate; oral

1.4

12.0

559

4134

ZXD35

NOMESCO Finland

Usual procedure

2.1

11.9

108

517

N99

ICPC

Neurological disease other

2.9

11.7

189

127

Kela drug reimbursment

Transplant complication

2.9

11.7

189

A02BC03

ATC

lansoprazole; oral

1.3

11.7

912

7316

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.5

11.7

112

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.6

11.6

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

30.1

11.6

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

11.6

122

N03AX23

ATC

brivaracetam; systemic

12.6

11.6

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

65.2

11.6

N02AA05

ATC

oxycodone; systemic

1.4

11.6

638

4853

R3120

NOMESCO Finland

Training in mobility skills

5.3

11.5

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

11.5

381

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.4

11.5

123

H47.4

ICD-10 Finland

Disorders of optic chiasm

+∞

11.5

P20

ICPC

Memory disturbance

1.4

11.5

506

3704

A04

ICPC

Weakness/tiredness general

1.4

11.4

514

3774

J01FA06

ATC

roxithromycin; oral

1.3

11.4

1245

10445

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

11.4

207

1244

H35.4

ICD-10 Finland

Peripheral retinal degeneration

3.9

11.4

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

11.3

242

1517

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

11.3

243

1525

R1250, ,

SPAT

2.1

11.3

106

514

C10AA03

ATC

pravastatin; oral

1.6

11.3

244

1533

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

11.8

11.3

E23.05

ICD-10 Finland

Lack of TSH

8.3

11.3

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

8.3

11.3

A12BA01

ATC

potassium chloride; oral

1.8

11.3

155

859

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

11.3

309

2056

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.0

11.2

125

646

L17

ICPC

Foot/toe symptom/complaint

1.3

11.2

971

7895

ZY010

NOMESCO Finland

Hospital outpatient

1.9

11.2

145

788

SPAT1252

SPAT

Overall medication plan or its review

1.7

11.2

225

1389

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

11.1

412

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

12.7

11.1

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

11.1

232

1447

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.3

11.1

126

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.3

11.1

126

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

11.0

685

5304

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

11.0

158

887

B01AB04

ATC

dalteparin; parenteral

1.8

11.0

166

947

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

4.8

10.9

A02BC05

ATC

esomeprazole; systemic

1.3

10.9

1275

10773

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

43.4

10.9

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

10.9

843

6746

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.5

10.9

103

D32.03

ICD-10 Finland

Benign meningioma in ventricles

10.6

10.8

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

28.1

10.7

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.6

10.7

227

R13

ICD-10 Finland

Dysphagia

1.6

10.7

238

1508

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.7

10.7

210

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

21.5

10.7

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.4

10.7

281

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

10.6

213

1314

C08CA13

ATC

lercanidipine; oral

1.4

10.6

475

3482

H54.0

ICD-10 Finland

Blindness, binocular

60.2

10.6

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

10.6

201

1222

A02BA02

ATC

ranitidine; systemic

1.4

10.6

602

4594

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

8.0

10.6

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

10.5

1153

9653

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

10.5

235

1490

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

10.5

384

2712

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

10.5

336

2311

S01EC01

ATC

acetazolamide; systemic

2.3

10.5

339

H02.4

ICD-10 Finland

Ptosis of eyelid

2.1

10.4

463

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

110.3

10.4

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

10.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

10.4

147

823

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.2

10.3

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

4.2

10.3

G91.8

ICD-10 Finland

Other hydrocephalus

16.1

10.3

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.8

10.3

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.3

10.3

PD5AD

NOMESCO Finland

CT of aorta

2.2

10.3

413

S01EE05

ATC

tafluprost; ophthalmic

1.9

10.3

126

674

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

18.8

10.2

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

10.2

285

1903

A10AB05

ATC

insulin aspart; parenteral

1.6

10.2

247

1598

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

10.2

1300

11085

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.2

542

4094

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

10.1

351

L04AX01

ATC

azathioprine; systemic

1.9

10.0

125

672

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.8

10.0

H02AB04

ATC

methylprednisolone; systemic

1.4

10.0

435

3175

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

9.9

596

4585

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.8

9.9

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

9.9

127

690

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

9.9

270

1796

N06AA09

ATC

amitriptyline; systemic

1.5

9.9

287

1935

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.8

656

5129

SPAT1234

SPAT

Support of social functional capacity

1.7

9.8

177

1063

L04AA01

ATC

[U] ciclosporin

2.8

9.8

163

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

9.8

176

1056

XF402

NOMESCO Finland

ECG with work load test

1.5

9.8

326

2261

H53.3

ICD-10 Finland

Other disorders of binocular vision

9.5

9.7

D68.8

ICD-10 Finland

Other specified coagulation defects

3.1

9.7

126

H43.3

ICD-10 Finland

Other vitreous opacities

2.8

9.7

175

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

9.7

289

1959

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.6

424

3099

S06.3

ICD-10 Finland

Focal brain injury

2.8

9.6

165

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

11.4

9.5

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

7.1

9.5

SAA04

NOMESCO Finland

Special examination of mouth

1.8

9.5

152

884

A29

ICPC

General symptom/complaint other

1.4

9.5

430

3160

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.3

9.4

108

R60.0

ICD-10 Finland

Localized oedema

1.4

9.4

409

2981

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

9.4

196

1222

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

100.3

9.4

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

7.5

9.4

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

17.6

9.4

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

17.6

9.4

R51.81

ICD-10 Finland

Facial pain NOS

2.2

9.4

343

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

9.4

275

1858

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

9.3

135

761

2151

FHL

Resection, big brain

21.7

9.3

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.2

9.3

114

H50.52

ICD-10 Finland

Exophoria

3.4

9.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.3

400

2911

H51.1

ICD-10 Finland

Convergence insufficiency and excess

9.5

9.3

SPAT1153

SPAT

Removal of sutures

1.3

9.2

988

8223

S01ED01

ATC

timolol; ophthalmic

1.9

9.2

116

626

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

9.2

140

801

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

7.3

9.2

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

13.7

9.2

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

3.9

9.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.1

532

4073

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

9.1

316

2209

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.4

9.1

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

9.1

207

1321

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

11.5

9.1

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

8.3

9.1

WX730

NOMESCO Finland

Conventional respirator

2.5

9.0

217

I50.1

ICD-10 Finland

Left ventricular failure

1.7

9.0

171

1041

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

9.0

263

1776

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

8.9

228

1493

SPAT1053

SPAT

Memory test

1.4

8.9

474

3573

C09AA02

ATC

enalapril; systemic

1.3

8.9

630

4959

R52.2

ICD-10 Finland

Other chronic pain

1.9

8.9

117

640

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

18.6

8.9

K84

ICPC

Heart disease other

2.0

8.9

513

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.1

8.9

A10AE04

ATC

insulin glargine; parenteral

1.5

8.9

303

2110

137

Kela drug reimbursment

Uraemia requiring dialysis

3.2

8.9

107

N06AX16

ATC

venlafaxine; oral

1.4

8.9

384

2796

A01

ICPC

Pain general/multiple sites

1.5

8.9

315

2212

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

8.8

345

H26.02

ICD-10 Finland

Presenil cataract

2.1

8.8

378

L03AX13

ATC

glatiramer acetate; parenteral

6.8

8.8

H25.0

ICD-10 Finland

Senile incipient cataract

1.6

8.8

212

1370

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.8

414

3059

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

8.8

233

1539

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

8.6

8.8

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

8.8

588

4595

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

9.5

8.8

R5110, ,

SPAT

1.5

8.7

279

1918

N02BF01

ATC

gabapentin; oral

1.5

8.7

311

2185

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

8.7

200

1278

J01DA01

ATC

[U] cefalexin

1.2

8.7

1961

17700

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

8.7

135

WF002

NOMESCO Finland

Radical radiotherapy

1.6

8.7

184

1153

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.2

8.7

315

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

8.7

223

1463

AAK00

NOMESCO Finland

Cranioplasty

14.0

8.7

XA400

NOMESCO Finland

EEG

3.9

8.7

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

50.1

8.7

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.6

8.5

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

8.5

148

880

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.1

8.5

110

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

8.5

435

3259

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

8.5

224

1478

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

27.6

8.5

RS222, ,

NOMESCO Finland

2.8

8.5

148

R35

ICD-10 Finland

Polyuria

1.5

8.5

224

1480

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.3

8.4

255

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.3

8.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

8.4

185

1170

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

90.3

8.4

S01EE03

ATC

bimatoprost; ophthalmic

2.1

8.4

399

SPAT1251

SPAT

Organisation of medication

1.8

8.4

112

617

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.1

8.4

346

C10AA07

ATC

rosuvastatin; oral

1.3

8.4

1038

8775

R06AE07

ATC

cetirizine; oral

1.2

8.3

1296

11232

G93.0

ICD-10 Finland

Cerebral cysts

4.7

8.3

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.7

8.3

135

788

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

8.3

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

+∞

8.3

AA4AD

NOMESCO Finland

CT of sella turcica

+∞

8.3

L04AX07

ATC

dimethyl fumarate; oral

8.5

8.3

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

8.3

463

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

8.3

263

1807

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

8.2

464

RS221, ,

NOMESCO Finland

2.6

8.2

185

ZX050

NOMESCO Finland

Stereotactic radiotherapy

2.9

8.2

134

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

8.2

204

1329

AAK80

NOMESCO Finland

Partial excision of skull cap

14.5

8.2

N04BB01

ATC

amantadine; oral

2.5

8.1

204

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

8.1

168

1047

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

8.1

198

1284

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

8.1

298

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

8.1

186

1189

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

8.1

516

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.1

1176

10113

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

17.2

8.1

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

3.8

8.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.0

1128

9662

SPAT1050

SPAT

Extensive neurological examination

2.1

8.0

326

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.1

8.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

8.0

156

959

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.5

8.0

R52.9

ICD-10 Finland

Pain, unspecified

1.4

8.0

298

2114

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

8.0

208

1371

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

7.9

105

577

SPAT1262

SPAT

Handing over of treatment supplies

1.3

7.9

537

4199

J01CA04

ATC

amoxicillin; systemic

1.2

7.9

2665

24965

SPAT1097

SPAT

Recording of ECG

1.4

7.9

438

3322

ZX120

NOMESCO Finland

Intravenous

1.5

7.9

282

1983

L16

ICPC

Ankle symptom/complaint

1.4

7.9

348

2543

H25.8

ICD-10 Finland

Other senile cataract

1.4

7.9

363

2673

S50.0

ICD-10 Finland

Contusion of elbow

2.0

7.8

445

H3603, E103,

ICD-10 Finland

3.3

7.8

M03BX02

ATC

tizanidine; oral

1.2

7.8

1877

16977

AA9CW, ,

NOMESCO Finland

9.4

7.8

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.0

7.8

111

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

7.7

235

1601

L04AG12

ATC

ofatumumab; parenteral

45.1

7.7

D21

ICPC

Swallowing problem

2.3

7.7

253

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.7

184

1189

GBB00

NOMESCO Finland

Tracheostomy

2.6

7.7

162

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

7.7

205

1358

ZXA00

NOMESCO Finland

Right side

1.3

7.7

811

6720

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.6

126

740

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

4.5

7.6

SPAT1240

SPAT

Therapeutic discussion

1.5

7.6

253

1754

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

7.6

115

659

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

18.4

7.6

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.0

7.6

360

H26.2

ICD-10 Finland

Complicated cataract

2.6

7.6

163

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

7.6

306

2201

A11

ICPC

Chest pain NOS

1.5

7.6

260

1815

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.6

268

1882

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.5

380

2840

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.5

7.5

WZC30

NOMESCO Finland

Teaching

1.3

7.5

508

3969

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.2

7.5

269

S22

ICPC

Nail symptom/complaint

1.5

7.5

200

1326

N30.0

ICD-10 Finland

Acute cystitis

1.3

7.4

504

3939

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

7.4

226

1539

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

7.4

H52.2

ICD-10 Finland

Astigmatism

2.3

7.4

251

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

80.3

7.4

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.4

7.4

201

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

7.4

132

793

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

13.4

7.4

N03AX15

ATC

zonisamide; oral

7.6

7.4

F28

ICPC

Limited function/disability (F)

3.4

7.4

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.3

7.4

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

7.3

115

666

I20.09

ICD-10 Finland

Unstable angina

1.6

7.3

183

1194

NHQ40

NOMESCO Finland

Amputation of toe

2.3

7.3

240

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

7.3

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

3.6

7.3

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

7.3

106

601

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.3

323

2363

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

3.1

7.3

XKC03

NOMESCO Finland

Water cystometry

1.9

7.3

478

H02AB07

ATC

prednisone; oral

1.4

7.3

400

3032

B05DA

ATC

Isotonic solutions

3.2

7.3

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

15.8

7.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

7.2

206

1385

UJF32

NOMESCO Finland

Coloscopy

1.3

7.2

810

6753

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.2

289

2077

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.2

2217

20465

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

7.2

109

626

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

7.1

134

816

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

7.1

176

1146

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

7.1

287

2064

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

20.0

7.1

RK320, ,

NOMESCO Finland

3.1

7.1

R03AC02

ATC

salbutamol; inhalant

1.2

7.1

1691

15222

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.2

7.1

A07AA02

ATC

nystatin; oral

1.6

7.1

172

1115

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

7.1

425

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

7.1

164

1052

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

7.1

135

826

C01AA05

ATC

digoxin; systemic

1.4

7.1

260

1840

H02AB02

ATC

dexamethasone; systemic

1.4

7.0

343

2549

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

8.8

7.0

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

7.0

357

N74

ICPC

Malignant neoplasm nervous system

10.0

7.0

R20.1

ICD-10 Finland

Hypoaesthesia of skin

3.6

7.0

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.3

7.0

219

ZXD20

NOMESCO Finland

Day surgery

1.4

7.0

362

2716

J01MA12

ATC

levofloxacin; systemic

1.3

7.0

565

4523

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

7.0

414

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.0

7.0

102

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.0

6.9

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

3.7

6.9

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4.0

6.9

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

13.8

6.9

D07AA02

ATC

hydrocortisone; topical

1.4

6.9

377

2855

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

2.6

6.9

142

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.9

531

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.8

793

6630

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.2

6.8

247

R07.3

ICD-10 Finland

Other chest pain

1.4

6.8

300

2191

C01BD01

ATC

amiodarone; systemic

1.8

6.8

481

K77

ICPC

Heart failure

1.9

6.8

403

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

8.3

6.8

S97

ICPC

Chronic ulcer skin

1.5

6.8

202

1370

L04AA31

ATC

[U] teriflunomide

6.7

6.8

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.7

6.8

C09AA04

ATC

perindopril; oral

1.6

6.8

149

944

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

2.9

6.8

109

G41.0

ICD-10 Finland

Grand mal status epilepticus

9.3

6.8

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.8

1171

10211

D35.3

ICD-10 Finland

Benign neoplasm: Craniopharyngeal duct

40.1

6.8

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

40.1

6.8

AAF15

NOMESCO Finland

Ventriculoatrial shunt

5.6

6.7

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.3

6.7

TK820

NOMESCO Finland

Peritoneal dialysis

3.6

6.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.7

360

2717

Z50.1

ICD-10 Finland

Other physical therapy

1.6

6.7

156

1003

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.7

1351

11953

2542

FHL

Transasal hypophysectomy

22.5

6.7

SPAT1101

SPAT

Orthostatic test

1.6

6.7

135

839

B01AE07

ATC

dabigatran etexilate; oral

1.7

6.7

121

731

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.7

272

1962

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

6.7

151

965

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.3

6.6

212

R41.3

ICD-10 Finland

Other amnesia

1.8

6.6

552

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.6

6.6

149

951

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

6.6

202

1379

A02BA04

ATC

nizatidine; systemic

1.5

6.6

219

1520

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

12.3

6.6

M04AA01

ATC

allopurinol; systemic

1.3

6.6

423

3281

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.6

271

1958

F43

ICPC

Eye, Other diagnostic procedure

2.0

6.6

325

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.6

156

1008

CA1ME

NOMESCO Finland

Ultrasound oculometry

3.2

6.6

C08CA05

ATC

nifedipine; systemic

1.5

6.5

184

1234

N76

ICPC

Neoplasm nervous system unspecified

8.7

6.5

P99

ICPC

Psychological disorders other

1.9

6.5

409

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

6.5

395

C08DB01

ATC

diltiazem; oral

1.6

6.5

163

1065

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

10.0

6.5

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

10.0

6.5

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

10.0

6.5

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

6.5

272

Z00.0

ICD-10 Finland

General medical examination

1.3

6.5

569

4598

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.2

6.5

233

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

6.5

111

660

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.5

511

F05.9

ICD-10 Finland

Delirium, unspecified

1.9

6.5

382

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

6.5

548

C02AC05

ATC

moxonidine; oral

1.6

6.5

143

908

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

6.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.5

136

854

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

6.5

313

2325

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

5.3

6.4

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

6.4

260

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.9

6.4

397

J01FA01

ATC

erythromycin; systemic

1.4

6.4

343

2586

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

6.4

362

SPAT1172

SPAT

Guidance concerning hydration

1.9

6.4

369

XCD20

NOMESCO Finland

Photoangiography of eye

2.2

6.4

247

WF099

NOMESCO Finland

Other radiotherapy

3.1

6.4

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

3.1

6.4

E22.80

ICD-10 Finland

Central precocious puberty

70.0

6.4

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

70.0

6.4

3069, ,

Kela drug reimbursment

70.0

6.4

PA6DG

NOMESCO Finland

Very extensive MRI examination of neck vasculature with high intensity magnet

70.0

6.4

1541, ,

Kela drug reimbursment

70.0

6.4

R4120, ,

SPAT

2.3

6.4

196

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

6.4

185

1248

164

Kela drug reimbursment

Fingolimod

7.4

6.4

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

7.4

6.4

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

6.4

335

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.4

205

1413

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

6.4

400

3090

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

6.4

121

740

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.4

767

6435

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.4

524

4202

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.4

1109

9666

I20.01

ICD-10 Finland

Unstable angina

1.8

6.3

537

M54.5

ICD-10 Finland

Low back pain

1.2

6.3

1082

9410

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

6.3

351

2663

M54.8

ICD-10 Finland

Other dorsalgia

1.6

6.3

127

788

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

6.3

140

891

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

11.0

6.3

F01.1

ICD-10 Finland

Multi-infarct dementia

11.0

6.3

I20.00

ICD-10 Finland

Unstable angina

1.8

6.3

531

UDC00

NOMESCO Finland

Ear microscopy

1.5

6.3

205

1418

J02AC01

ATC

fluconazole; systemic

1.2

6.3

1079

9388

C04AE01

ATC

ergoloid mesylates; systemic

3.5

6.3

D32

ICD-10 Finland

Benign neoplasm of meninges

18.0

6.3

E23.0

ICD-10 Finland

Hypopituitarism

18.0

6.3

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.3

6.3

192

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

6.2

9350/1-C75.1

ICD-O-3

Craniopharyngioma, NOS, of pituitary gland

+∞

6.2

H53.5

ICD-10 Finland

Colour vision deficiencies

26.7

6.2

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

6.2

339

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.8

6.2

526

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.2

6.2

212

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.7

6.2

F29

ICPC

Eye symptom/complaint other

1.4

6.2

288

2125

N05CD07

ATC

temazepam; oral

1.3

6.2

348

2647

C01BC04

ATC

flecainide; systemic

1.7

6.2

564

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.2

925

7940

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

6.2

102

602

Z01.2

ICD-10 Finland

Dental examination

1.2

6.1

1336

11877

G43.8

ICD-10 Finland

Other migraine

2.4

6.1

169

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

6.1

156

1026

Z00.8

ICD-10 Finland

Other general examinations

1.4

6.1

218

1536

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

6.1

344

2618

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.1

6.1

253

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

6.1

160

1059

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.1

565

4600

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.1

6.1

280

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.8

6.1

427

M89.0

ICD-10 Finland

Algoneurodystrophy

3.0

6.1

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

6.1

349

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

6.1

109

658

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.3

6.0

195

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

8.6

6.0

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.5

6.0

158

1044

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.9

6.0

R06.4

ICD-10 Finland

Hyperventilation

2.4

6.0

164

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

6.0

231

1649

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1825

10188

2.58

168.73

2.8

2.2

163.53

231.23

u/l

3.29

1751

9616

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1103

5082

2.67

147.98

2.9

2.1

29.21

29.77

2.49

1072

4936

(3032080) INR in Blood by Coagulation assay

2250

15609

2.14

105.00

22.4

16.5

1.35

1.29

inr

4.55

1951

13111

(3013826) Glucose [Moles/volume] in Serum or Plasma

2559

19234

2.10

88.95

7.3

5.2

6.67

6.78

mmol/l

1.91

2482

18270

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2065

15104

1.84

69.01

8.8

6.8

1.20

1.21

mmol/l

3.81

1936

13953

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2245

16901

1.85

67.77

9.6

7.5

1.21

mmol/l

3.14

1929

14550

(3036481) Cortisol [Moles/volume] in Serum or Plasma

621

3047

2.25

66.27

3.6

2.2

361.07

380.67

nmol/l

0.77

575

2813

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

185

6.04

61.52

1.8

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

761

4162

2.05

60.87

8.7

7.8

13.41

12.12

kpa

6.95

729

3984

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

761

4163

2.05

60.82

8.7

7.8

5.02

5.11

kpa

1.77

732

3988

(3019977) pH of Arterial blood

755

4149

2.03

59.44

8.9

7.9

7.42

0.72

463

2283

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

237

773

3.21

57.16

1.6

1.3

635.53

567.31

mg/l

0.51

228

736

(3003396) Base excess in Arterial blood by calculation

744

4122

2.01

57.00

8.8

7.8

0.73

1.05

mmol/l

1.33

616

3363

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

134

301

4.58

55.20

1.9

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1737

12579

1.72

55.19

5.1

4.0

87.06

101.78

ng/l

0.12

1340

9181

(3021387) Prolactin [Units/volume] in Serum or Plasma

251

883

2.98

53.09

3.8

1.6

343.00

299.38

mu/l

0.89

239

811

(3023368) Bacteria identified in Blood by Culture

1408

9696

1.73

53.05

4.9

4.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

212

685

3.22

51.88

1.8

1.4

1199.41

1313.85

e6/l

0.06

180

548

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

209

673

3.23

51.43

1.7

1.4

74.50

32.68

e6/l

0.37

168

504

(3036489) Thrombin time

294

1165

2.66

49.63

2.8

2.0

21.18

21.35

0.18

250

1050

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

209

691

3.15

49.19

1.4

1.3

3.66

3.84

mmol/l

1.32

195

660

(3033658) Prothrombin time (PT) actual/Normal

1227

8312

1.72

47.86

5.1

4.2

87.94

87.59

0.17

1202

8141

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

126

6.39

47.43

2.6

2.3

59.96

51.07

umol/l

0.99

110

(3024561) Albumin [Mass/volume] in Serum or Plasma

1954

14993

1.65

46.88

5.8

5.1

35.19

35.27

g/l

0.25

1842

14067

(3018418) pH of Serum or Plasma

1440

10227

1.67

46.77

4.9

4.2

7.40

0.47

1084

7404

(3002173) Hemoglobin [Mass/volume] in Arterial blood

616

3435

1.95

45.33

10.0

8.6

121.50

120.91

g/l

0.30

597

3350

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

931

5941

1.76

44.35

2.1

1.9

—

(3016502) Oxygen saturation in Arterial blood

648

3706

1.91

44.11

9.5

8.1

95.85

95.53

0.62

622

3571

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

16.52

42.69

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

104

235

4.53

42.53

1.6

1.3

2.31

2.25

mmol/l

0.10

219

(3026008) Bacteria identified in Urine by Culture

1422

10276

1.63

41.81

3.8

3.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

197

4.82

41.15

1.2

1.1

46.18

39.72

mg/l

0.56

162

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

179

5.01

40.83

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

889

5752

1.72

39.64

4.0

3.4

0.82

mmol/l

0.13

836

5418

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

193

4.76

39.25

1.1

308.55

274.60

mg/l

0.28

165

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2138

17261

1.57

37.75

7.2

6.7

11.01

11.91

umol/l

3.66

2018

16498

(3031040) Bacteria [#/volume] in Urine by Automated count

2512

21103

1.61

36.97

6.1

4.9

4292.36

1833.53

e6/l

0.43

316

(3001604) Monocytes [#/volume] in Blood

2042

16416

1.55

35.92

7.5

6.2

0.61

0.60

e9/l

0.60

1799

14017

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

5.23

35.65

1.7

1.6

—

(3006315) Basophils [#/volume] in Blood

2043

16456

1.55

35.39

7.5

6.2

0.04

e9/l

0.41

1798

14051

(3008152) Bicarbonate [Moles/volume] in Arterial blood

415

2187

2.01

35.39

8.3

6.9

24.68

24.52

mmol/l

0.40

396

2080

(4027681) Cerebrospinal fluid IgG ratio and IgG index

147

5.12

35.30

1.4

1.2

0.69

0.54

ratio

1.30

(3013115) Eosinophils [#/volume] in Blood

2092

16945

1.55

35.28

7.9

6.5

0.19

e9/l

0.13

1854

14712

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

231

973

2.47

34.15

3.6

2.2

96.92

91.96

2.90

218

943

(3019198) Lymphocytes [#/volume] in Blood

2065

16759

1.53

33.88

7.6

6.3

1.81

1.90

e9/l

1.13

1848

14682

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

706

4453

1.73

33.86

2.0

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1408

10574

1.54

32.79

3.7

3.2

1712.72

1570.76

ng/l

0.55

1225

9180

(3003458) Phosphate [Moles/volume] in Serum or Plasma

722

4625

1.70

32.58

7.0

6.1

1.03

1.04

mmol/l

0.54

674

4305

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

669

4205

1.72

32.34

2.0

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2809

24547

1.62

32.13

9.9

8.4

80.66

80.55

u/l

0.03

2674

23309

(3009466) Valproate [Moles/volume] in Serum or Plasma

133

435

3.14

31.86

4.2

5.5

352.45

352.09

umol/l

0.01

122

388

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

942

6590

1.58

29.45

5.1

4.0

298.31

561.26

ng/l

0.92

746

5357

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2681

23365

1.55

29.06

5.3

4.4

13.00

12.75

mm/h

0.37

2538

21813

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

374

2049

1.92

28.24

11.9

10.4

16.21

15.92

1.19

356

1969

(3023410) Appearance of Cerebral spinal fluid

100

296

3.45

28.17

1.8

1.5

—

(3019069) Monocytes/Leukocytes in Blood

1869

15198

1.47

27.98

8.1

6.6

9.05

8.96

0.73

1788

14231

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

204

895

2.35

27.52

3.3

2.4

185.08

196.20

0.96

197

850

(3006504) Eosinophils/Leukocytes in Blood

1858

15155

1.46

26.98

8.0

6.5

2.76

2.83

0.73

1776

14190

(3013650) Neutrophils [#/volume] in Blood by Automated count

2190

18441

1.47

26.87

10.7

9.5

4.28

4.19

e9/l

0.99

1937

15955

(3022096) Basophils/Leukocytes in Blood

1854

15145

1.45

26.53

8.1

6.6

0.65

0.67

1.02

1771

14163

(3018010) Neutrophils/Leukocytes in Blood

1859

15200

1.45

26.43

7.8

6.4

58.53

57.82

1.75

1803

14502

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

125

441

2.90

26.26

1.4

1.2

8.81

3.73

u/ml

0.93

196

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

106

5.16

26.15

3.8

2.6

30.67

29.18

umol/l

0.39

(3019309) Folate [Moles/volume] in Red Blood Cells

851

5962

1.56

25.93

1.9

1.8

1161.28

1165.89

nmol/l

0.05

647

4533

(3002030) Lymphocytes/Leukocytes in Blood

1885

15500

1.45

25.71

8.0

6.5

26.24

27.09

2.69

1817

14672

(4195642) Thrombophilia screening test

118

408

2.96

25.70

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

143

4.47

25.69

1.1

1.27

1.18

u/l

0.24

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

970

7027

1.52

25.23

2.1

1.7

1.26

1.37

mg/l

0.44

752

5489

(3020779) Urea [Moles/volume] in Serum or Plasma

520

3268

1.69

24.60

8.2

7.3

9.61

10.38

mmol/l

1.53

487

3135

(3007930) Methemoglobin/Hemoglobin.total in Blood

285

1492

1.99

24.50

7.3

5.5

0.90

0.87

0.69

267

1407

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

157

4.20

24.49

1.1

1.2

1.06

1.07

ratio

0.17

130

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

264

3.39

24.31

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

1244

9534

1.46

24.26

4.2

3.4

0.44

0.45

e6/l

0.08

988

7055

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.91

24.17

1.4

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1197

9117

1.46

24.06

2.7

2.4

2.92

2.87

mg/l

0.37

1033

7867

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1838

15155

1.43

24.02

3.2

2.8

—

estimate

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

300

1616

1.93

23.72

7.1

5.2

1.74

1.61

1.00

280

1527

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

371

2147

1.81

23.42

10.6

9.7

23.89

24.27

mmol/l

1.41

365

2106

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

242

1214

2.06

23.41

4.1

2.9

0.40

0.34

iu/ml

1.91

134

669

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

469

2904

1.71

23.38

2.5

2.4

5.59

7.18

ug/l

1.82

403

2558

(3015736) pH of Urine

1668

13564

1.42

23.29

4.3

3.5

6.27

6.25

0.25

915

7603

(3044640) Blood type and Crossmatch panel - Blood

1364

10711

1.44

23.05

2.9

2.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

114

413

2.82

22.84

1.1

1.2

119.97

114.62

1.04

108

378

(3026782) Osmolality of Urine

911

6639

1.50

22.62

3.4

3.0

516.42

534.12

mosm/kgh2o

1.68

822

5845

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

121

456

2.71

22.49

1.4

1.2

6.45

2.59

u/ml

0.91

166

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

283

3.20

22.41

2.6

1.6

361.65

329.72

mu/l

0.27

227

(3035350) Ketones [Presence] in Urine by Test strip

2020

17059

1.41

22.36

4.9

4.0

6.04

3.19

estimate

0.28

472

3709

(3009261) Glucose [Presence] in Urine by Test strip

2029

17165

1.41

22.13

5.0

4.0

0.02

0.10

estimate

0.40

441

3460

(3039000) Anion gap in Blood by calculation

165

727

2.33

22.05

9.6

7.5

11.16

11.34

mmol/l

0.27

147

648

(3022948) Iron [Moles/volume] in Serum or Plasma

829

5954

1.51

22.00

3.1

2.7

12.13

12.68

umol/l

1.36

756

5563

(3018572) Chloride [Moles/volume] in Blood

165

728

2.33

21.98

9.6

7.5

104.78

105.04

mmol/l

0.23

147

649

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

154

4.01

21.70

1.1

—

(3008295) Osmolality of Serum or Plasma

105

379

2.82

21.20

1.7

1.4

284.04

277.49

mosm/kgh2o

2.13

290

(3021601) Nitrite [Presence] in Urine by Test strip

1989

16843

1.40

21.12

4.9

4.0

0.00

estimate

0.41

457

3622

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1318

10411

1.42

21.03

3.2

2.7

59.83

68.34

u/l

0.47

1226

9651

(3000850) Epithelial cells [#/volume] in Urine

1022

7716

1.45

20.89

3.4

2.8

4.76

5.42

e6/l

1.24

952

7050

(3002582) Erythrocytes [#/volume] in Urine

1389

11082

1.41

20.89

4.4

3.5

54.93

84.36

e6/l

1.44

1129

8510

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

200

979

2.10

20.65

3.7

2.4

3.40

3.58

g/l

1.07

192

923

(3009214) Lutropin [Units/volume] in Serum or Plasma

167

762

2.25

20.57

2.1

1.4

9.78

10.03

u/l

0.08

125

620

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

190

917

2.13

20.35

2.0

1.6

0.23

0.24

g/l

0.46

178

873

(3047181) Lactate [Moles/volume] in Blood

209

1050

2.05

20.13

8.6

6.4

1.29

1.33

mmol/l

0.18

183

920

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3257

30360

1.66

20.05

24.6

17.3

23.23

25.40

mg/l

3.91

2878

25311

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

193

945

2.10

19.91

2.0

1.6

1.18

g/l

0.02

181

899

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

238

1258

1.95

19.86

2.3

2.2

315.01

679.16

ug/l

1.42

231

1191

(3019550) Sodium [Moles/volume] in Serum or Plasma

3320

31124

1.71

19.72

30.2

20.5

139.54

139.64

mmol/l

1.36

3265

30524

(3021960) Folate [Moles/volume] in Serum or Plasma

1247

9845

1.40

19.61

1.8

1.7

20.26

20.16

nmol/l

0.08

1089

8348

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

407

2540

1.68

19.54

1.8

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.82

19.39

1.1

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3322

31186

1.70

19.13

30.3

20.7

3.98

mmol/l

0.91

3264

30532

(3004789) Transferrin [Mass/volume] in Serum or Plasma

769

5577

1.48

19.10

3.1

2.7

2.32

2.29

g/l

0.85

703

5158

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2655

23808

1.42

18.97

5.3

4.3

14.89

14.84

pmol/l

0.52

2435

21802

(4268621) Lupus anticoagulant assay

314

2.88

18.77

2.6

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

595

4125

1.53

18.31

4.2

232.77

247.87

u/l

2.02

561

3908

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

107

4.34

18.26

1.0

1.1

95.49

94.04

0.12

(3027945) Reticulocytes/Erythrocytes in Blood

605

4223

1.52

18.00

2.6

1.80

1.79

0.08

543

3756

(3005719) IgG [Mass/volume] in Serum or Plasma

392

2475

1.65

17.95

3.2

2.9

10.66

10.57

g/l

0.13

355

2277

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1735

14602

1.36

17.87

2.7

2.4

76.95

78.15

nmol/l

1.00

1590

13140

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

107

427

2.55

17.80

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1510

12445

1.36

17.76

5.2

4.1

130.11

101.73

e6/l

0.45

1146

8877

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

712

5152

1.47

17.74

3.2

2.7

21.05

22.50

2.00

657

4796

(3023520) Reticulocytes [#/volume] in Blood

491

3288

1.57

17.61

2.6

66.69

69.03

e9/l

0.78

368

2418

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1762

14891

1.35

17.53

2.3

2.2

95.94

95.09

pmol/l

0.29

956

7919

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

167

3.45

16.43

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

560

3928

1.50

16.15

2.1

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1399

11539

1.34

15.81

3.7

3.5

2.34

2.35

mmol/l

1.80

1267

10490

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

305

1865

1.69

15.73

3.6

3.4

4.29

4.46

pmol/l

1.87

277

1651

(3014111) Lactate [Moles/volume] in Serum or Plasma

472

3223

1.53

15.41

9.3

7.6

1.33

1.36

mmol/l

0.22

463

3165

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

160

3.41

15.32

1.8

2.3

1737.63

1140.33

u/ml

0.23

160

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2286

20311

1.33

15.17

4.0

3.3

54.91

50.72

u/l

0.94

2153

18971

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

232

1327

1.80

15.14

1.7

1.9

37.25

39.24

u/l

0.81

205

1165

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

325

2043

1.65

15.07

2.5

2.4

12.42

20.26

au/ml

2.70

197

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

210

1167

1.85

15.06

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

136

650

2.13

14.99

1.6

1.4

72.82

60.94

mmol/l

1.94

117

515

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

302

1869

1.67

14.88

1.3

59.57

54.73

au/ml

0.10

126

(3009445) Proteinase 3 Ab [Units/volume] in Serum

241

1406

1.76

14.71

1.5

25.83

17.46

iu/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1027

8156

1.36

14.62

2.8

2.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.99

14.31

1.1

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

990

7843

1.36

14.25

4.8

3.8

0.75

0.08

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1298

10709

1.33

14.22

3.7

3.3

32.45

36.52

u/l

0.77

1214

10106

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1738

14937

1.31

14.20

3.6

3.1

146.05

132.44

ug/l

0.83

1611

13921

(3009343) pH of Capillary blood

345

2237

1.60

14.10

4.5

3.9

7.41

7.42

0.17

290

1864

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3031

28259

1.42

14.00

6.2

5.3

1.89

1.95

mu/l

1.12

2796

26046

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

150

3.37

13.94

1.5

1.3

53.00

66.95

—

(3029937) Albumin [Presence] in Urine by Test strip

1169

9523

1.33

13.91

5.2

4.1

0.00

estimate

1.74

424

3318

(3023183) Ammonium ion [Moles/volume] in Plasma

148

752

2.01

13.87

2.9

2.8

32.71

36.14

umol/l

0.82

137

671

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

352

2308

1.58

13.71

4.5

3.9

5.12

5.15

kpa

0.23

331

2207

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

189

3.05

13.51

2.0

2.5

231.56

208.55

e6/l

0.41

168

(3011412) CD3 cells [#/volume] in Blood

289

2.63

13.48

2.0

2.3

1235.13

1154.78

e6/l

0.39

259

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

308

1973

1.61

13.22

4.6

3.7

1.51

1.96

mmol/l

1.37

218

1442

(3020630) Protein [Mass/volume] in Serum or Plasma

439

3057

1.50

12.96

2.4

2.6

65.66

66.22

g/l

0.80

397

2801

(3044889) 12 lead EKG panel

2428

21991

1.31

12.75

5.1

4.2

0.20

8241.06

—

(3012544) pH of Venous blood

514

3707

1.45

12.68

5.3

3.8

7.37

7.38

1.02

327

2170

(3021447) Carbon dioxide [Partial pressure] in Venous blood

509

3665

1.45

12.67

5.2

3.8

5.83

kpa

0.05

494

3568

(3000991) Gas panel - Venous blood

440

3091

1.48

12.42

11.8

8.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

410

2841

1.50

12.38

3.7

3.0

252.40

214.49

ng/l

0.90

373

2605

(40761511) CBC panel - Blood by Automated count

3263

30987

1.49

12.32

22.2

15.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

270

1710

1.63

12.14

1.7

1.8

1.57

1.53

g/l

0.26

239

1479

(3023323) Follitropin [Units/volume] in Serum or Plasma

213

1272

1.72

11.99

1.8

1.4

25.48

27.72

iu/l

0.42

167

1090

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

396

2751

1.49

11.80

4.4

4.0

1.22

1.23

mmol/l

1.21

353

2371

(3006245) CD3-CD19+ cells/cells in Blood

102

3.65

11.76

2.2

2.1

11.74

9.22

0.58

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1487

12727

1.28

11.74

4.9

4.0

1.30

0.07

estimate

0.47

390

2969

(3043409) Potassium [Moles/volume] in Arterial blood

167

936

1.82

11.70

4.5

4.0

3.84

3.89

mmol/l

0.84

167

926

(3000060) B lymphocytes [#/volume] in Blood

4.35

11.68

2.1

2.0

0.17

e9/l

0.02

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

153

835

1.87

11.66

1.7

1.9

11.82

11.92

mg/l

0.04

140

772

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

482

3488

1.44

11.63

4.5

3.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

195

2.85

11.63

1.9

2.4

486.85

534.63

e6/l

0.27

160

(3021589) Normoblasts [#/volume] in Blood

1640

14222

1.28

11.61

15.1

12.0

0.00

e9/l

0.05

1371

11603

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

327

2189

1.54

11.60

1.8

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

484

2.14

11.53

5.7

6.5

11.39

12.27

mg/l

1.25

453

(1616796) Gas panel - Central venous blood

146

797

1.87

11.14

4.2

4.0

—

(3042936) Bacteria identified in Isolate by Culture

631

4840

1.37

10.79

2.3

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

753

5934

1.34

10.79

3.9

3.1

1.02

1.09

e6/l

0.25

432

3169

(40758558) Short blood count panel - Blood

1169

9783

1.29

10.78

7.0

6.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

110

3.39

10.53

1.1

70.25

260.07

ng/l

—

(3012501) Base excess in Blood by calculation

132

711

1.89

10.51

5.1

4.6

2.39

2.70

mmol/l

0.82

486

(3023420) DNA double strand Ab [Units/volume] in Serum

210

1295

1.66

10.51

2.2

1.8

11.21

7.03

iu/ml

1.26

313

(3002032) Base excess in Venous blood by calculation

484

3574

1.41

10.38

5.2

3.8

1.49

1.87

mmol/l

1.95

415

3099

(3014148) Varicella zoster virus Ab [Titer] in Serum

360

2.25

10.35

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

197

1204

1.67

10.21

2.0

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

194

1183

1.68

10.14

1.3

1.2

0.28

1.08

u/ml

1.60

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

223

2.58

10.03

1.8

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

561

4278

1.37

9.89

1.5

1.3

598.23

497.59

titre

0.66

113

948

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

209

1313

1.63

9.74

2.0

—

(3045716) Anion gap in Serum or Plasma by calculation

385

2.16

9.59

3.1

3.0

10.27

10.77

mmol/l

0.74

380

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

156

912

1.74

9.53

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

594

1.91

9.39

1.3

1.2

230.00

454.58

titre

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3346

32185

1.46

9.25

31.7

22.5

81.72

79.76

umol/l

2.31

3310

31785

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

867

7114

1.29

9.05

1.9

1.8

10000448.38

24865478.43

pmol/l

0.70

700

5928

(3028026) IgM [Mass/volume] in Serum or Plasma

287

1973

1.49

8.98

2.2

1.9

1.33

1.37

g/l

0.08

266

1807

(3024354) Oxygen [Partial pressure] in Venous blood

416

3066

1.40

8.98

4.3

3.2

4.44

4.50

kpa

0.30

405

2978

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

270

1835

1.51

8.93

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

230

1511

1.56

8.89

2.3

1.9

2.26

2.41

ug/l

0.07

187

1331

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.33

8.86

2.0

2.2

20.43

16.89

umol/l

0.54

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

496

3772

1.36

8.85

9.7

7.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

7.95

8.84

1.1

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.25

8.61

1.6

1.2

37.40

18.54

—

(40761536) Microorganisms panel - Urine sediment

356

2578

1.42

8.49

5.1

4.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.65

8.34

1.1

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

392

2897

1.40

8.32

4.2

4.3

0.83

0.73

0.23

143

878

(3019150) Specific gravity of Urine by Refractometry

904

7527

1.27

8.28

5.3

4.2

1.02

1.22

kg/l

0.50

635

5082

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1298

1.57

8.18

2.3

2.2

9.68

10.34

g/l

1.46

177

1159

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

148

892

1.69

8.14

1.6

—

(3035715) Granulocytes [#/volume] in Blood

106

580

1.85

8.12

3.7

3.3

3.74

4.19

e9/l

1.92

106

580

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

3.10

7.97

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.28

7.92

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

313

2244

1.43

7.90

4.5

3.2

127.87

128.13

g/l

0.07

300

2180

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.44

7.89

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

492

3805

1.34

7.83

2.8

7.35

8.91

umol/l

0.95

422

3372

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

193

1258

1.56

7.76

2.8

3.4

29.67

63.88

mg/l

1.99

167

1067

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

360

2654

1.40

7.75

4.9

4.0

104.21

92.00

ng/l

1.18

314

2276

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

185

1195

1.58

7.73

5.7

4.1

24.63

24.86

mmol/l

0.48

165

1105

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

312

2.14

7.66

2.4

2.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

816

6766

1.27

7.66

2.9

3.0

2.45

2.46

mmol/l

0.59

735

6052

(3017446) Testosterone [Moles/volume] in Serum or Plasma

355

2617

1.39

7.64

3.6

2.3

12.49

12.85

nmol/l

0.34

322

2331

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

119

688

1.75

7.63

7.3

5.7

394.16

2962.03

iu/ml

0.55

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

157

980

1.63

7.57

2.0

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

192

1258

1.56

7.55

2.8

3.4

41.01

99.31

mg/l

0.75

165

1065

(44790047) Parainfluenza type 1 nucleic acid detection

444

1.94

7.53

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

444

1.94

7.53

1.5

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

444

1.94

7.53

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

444

1.94

7.53

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

766

1.71

7.53

1.5

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

547

1.83

7.39

3.7

3.0

104.86

1680.10

u/ml

—

(3000494) Fungus identified in Specimen by Culture

498

3894

1.32

7.33

1.7

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

174

1123

1.58

7.32

2.7

3.2

3.98

2.58

ratio

0.24

100

646

(3025159) Blasts/Leukocytes in Blood

388

2931

1.36

7.19

4.3

4.6

0.57

0.23

0.30

120

749

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.49

7.17

1.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

670

5464

1.28

7.17

4.1

3.2

2.52

2.26

e6/l

0.27

342

2694

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1494

1.50

7.16

2.2

3.67

3.74

g/l

0.28

198

1366

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

438

1.92

7.15

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1496

1.49

7.11

2.2

4.14

4.19

g/l

0.51

198

1369

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1496

1.49

7.11

2.2

7.36

7.43

g/l

0.23

198

1367

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

461

1.89

7.07

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

12.03

7.07

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

107

615

1.76

7.03

1.3

—

64.68

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

670

1.72

6.93

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

670

1.72

6.93

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3297

31844

1.35

6.91

15.8

12.4

25.61

25.71

u/l

0.11

3201

30894

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3042

29076

1.27

6.81

23.3

16.9

78.11

78.51

ml/min/173m2

0.46

2878

27022

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.15

6.70

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1400

1.49

6.68

2.1

2.3

2.94

g/l

0.01

183

1272

(3048689) Calprotectin [Mass/mass] in Stool

488

3856

1.31

6.64

2.1

2.4

157.99

144.13

ug/g

0.26

389

3096

(3007164) IgA [Mass/volume] in Serum or Plasma

738

6144

1.25

6.59

1.7

1.5

2.29

2.50

g/l

2.03

444

3790

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1961

17978

1.20

6.53

2.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

549

1.77

6.45

2.0

1.9

4.71

4.89

mmol/24h

0.23

482

(3035933) Granulocytes/Leukocytes in Blood

115

696

1.67

6.31

3.7

3.2

57.08

58.32

0.52

115

696

(3014051) Protein [Presence] in Urine by Test strip

1032

8944

1.21

6.25

3.5

3.0

0.05

0.04

0.05

236

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3005

28751

1.25

6.22

7.5

6.6

39.84

39.60

mmol/mol

0.77

2808

26818

(3005322) IgE [Units/volume] in Serum or Plasma

270

1969

1.40

6.22

1.3

284.04

208.38

u/ml

0.33

251

1816

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

661

1.68

6.21

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

574

1.73

6.08

1.4

1.3

318.02

274.74

u/ml

0.67

344

(3017181) Myelocytes/Leukocytes in Blood

395

3069

1.32

6.06

4.2

4.4

0.91

0.93

0.04

136

950

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.09

6.03

1.2

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

228

1628

1.43

5.93

4.3

3.4

25.05

25.31

mmol/l

0.56

215

1572

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.01

5.89

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

137

885

1.57

5.81

1.3

—

(4035726) Immunohistochemistry procedure

375

2910

1.32

5.81

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3047

29250

1.25

5.80

5.9

5.3

5.97

5.98

mmol/l

0.21

2807

26763

(40768797) Stomach Pathology biopsy report

549

4482

1.26

5.75

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

356

1.90

5.73

1.4

1.6

—

(44806071) Cardiolipin IgM antibody measurement

5.18

5.69

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.18

5.69

1.1

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

510

1.74

5.69

1.7

1.6

0.67

0.82

g/l

0.77

399

(4198724) Urine methamphetamine measurement

2.84

5.66

1.3

2.0

—

(3019225) pH of Specimen

402

3161

1.31

5.66

5.3

4.4

7.34

7.35

0.32

310

2265

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

12.88

5.58

1.1

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

424

3366

1.29

5.56

2.1

2.2

0.21

g/l

0.10

395

3146

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

162

1097

1.50

5.55

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

2.39

5.46

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.90

5.45

1.2

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

1291

11534

1.18

5.45

3.7

3.4

7.09

7.42

mmol/l

1.97

1115

9728

(3008757) Leukocyte morphology finding [Identifier] in Blood

335

1.90

5.40

3.9

4.0

—

(3014271) Vancomycin [Susceptibility]

161

2.31

5.34

2.7

3.0

—

(3022313) Gas panel - Capillary blood

214

1541

1.41

5.33

5.4

4.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

155

2.34

5.32

1.1

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

156

1058

1.50

5.32

1.9

2.1

0.00

g/l

-0.00

138

926

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

254

2.02

5.28

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

2.72

5.26

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1025

8999

1.19

5.25

4.2

3.5

0.01

0.23

estimate

1.03

379

2840

(40759836) Histone Ab [Presence] in Serum by Immunoblot

248

2.03

5.23

1.2

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

373

2935

1.30

5.23

4.3

4.5

0.08

0.12

0.69

114

817

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.23

5.16

1.6

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

384

1.81

5.15

1.5

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

107

673

1.61

5.12

2.4

1.9

181.29

204.70

pmol/l

1.32

101

633

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

100

619

1.63

5.10

1.5

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

986

1.50

5.10

2.0

2.1

0.00

g/l

-0.00

137

925

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.20

5.07

1.9

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

150

1023

1.49

5.00

5.5

3.6

1.74

1.60

mg/l

1.00

137

927

(3034426) Prothrombin time (PT)

2.70

5.00

1.4

1.3

29.36

28.73

0.10

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.01

4.98

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.01

4.98

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.64

4.98

1.1

87.23

88.44

0.08

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.82

4.97

1.2

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

135

903

1.51

4.95

3.7

3.4

1.83

2.05

index

0.22

452

(3004451) EKG impression Narrative

213

2.08

4.93

1.5

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

241

2.00

4.88

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

212

2857

0.73

4.85

2.0

3.36

3.44

ratio

0.42

165

2227

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

235

2.01

4.84

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

731

1.56

4.82

1.4

1.2

3.90

6.07

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.59

4.80

1.2

1.1

85.50

86.67

0.04

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

181

1291

1.42

4.79

2.2

2.3

0.81

0.99

g/l

0.30

155

1108

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2934

28188

1.21

4.79

4.8

4.3

1.32

1.28

mmol/l

2.25

2718

25777

(3006184) Hemoglobin [Mass/volume] in Capillary blood

131

878

1.51

4.77

2.4

2.3

133.35

127.92

g/l

1.49

104

685

(3017704) Immunofixation for Urine

203

2.08

4.74

1.3

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

546

1.65

4.73

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

314

2448

1.31

4.73

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.80

4.71

1.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

231

2.00

4.69

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

393

3161

1.27

4.65

2.9

2.5

118.32

55.25

u/l

0.33

343

2652

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

859

1.51

4.64

1.1

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

375

1.77

4.64

1.6

57.18

60.99

0.29

234

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.91

4.60

5.8

8.6

5.93

5.39

kpa

0.33

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

156

1095

1.44

4.52

2.0

2.1

0.03

0.02

g/l

0.19

140

982

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

131

889

1.49

4.51

1.5

1.3

6.99

8.00

u/ml

0.11

135

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

744

1.54

4.49

1.6

—

(40768446) Kidney Pathology biopsy report

123

2.37

4.48

1.8

1.6

—

(3024928) Oxygen saturation in Venous blood

133

908

1.48

4.45

5.0

2.9

61.35

60.62

0.14

128

882

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

103

667

1.56

4.41

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1.85

4.37

1.2

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2640

25198

1.17

4.35

29.7

21.2

13.85

13.72

4.77

2611

24857

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

128

872

1.48

4.34

2.4

1.8

46.80

42.24

nmol/l

0.89

123

843

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

138

2.26

4.31

1.1

0.12

8.56

nmol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

130

890

1.48

4.30

1.5

1.2

13.04

3.00

u/ml

1.22

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

184

2.08

4.30

2.1

2.8

39.89

39.75

0.01

106

(40760892) CBC W Ordered Manual Differential panel - Blood

811

7084

1.19

4.29

5.5

4.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

146

1023

1.44

4.29

1.8

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

127

866

1.48

4.29

1.1

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

136

943

1.46

4.23

1.5

1.2

52.64

37.87

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

179

2.08

4.20

1.2

1.3

135.92

132.62

nmol/l

0.19

179

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.15

4.20

6.7

8.4

10.52

10.41

0.06

(3012516) Albumin [Mass/volume] in Urine

1217

10998

1.16

4.20

3.8

3.5

50.84

47.58

mg/l

0.23

817

7129

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

653

1.55

4.15

1.6

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

127

873

1.47

4.13

1.1

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

801

7013

1.18

4.11

1.4

1.3

1.73

1.60

u/ml

0.10

200

1851

(3020682) Albumin/Creatinine [Ratio] in Urine

1241

11247

1.16

4.09

4.6

4.2

10.66

8.93

mg/mmol

0.56

802

7090

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

4.09

1.4

2.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

279

1.84

4.09

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

244

1.90

4.06

2.0

1.5

1.00

1.10

promille

0.21

195

(3042733) HLA Ab [Presence] in Serum

2.51

4.04

5.7

4.6

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3356

32803

1.28

4.03

37.6

26.5

39.81

40.20

1.70

3320

32393

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

326

2611

1.27

4.02

3.3

2.8

62.56

63.82

ml/min/173m2

0.22

152

1142

(3007461) Platelets [#/volume] in Blood

3355

32796

1.27

3.99

36.8

26.1

246.30

247.75

e9/l

0.62

3300

32094

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.44

3.98

6.1

5.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

304

2418

1.28

3.96

1.5

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3355

32801

1.27

3.95

36.6

26.0

91.58

91.35

2.15

3318

32409

(3035941) MCH [Entitic mass]

3355

32802

1.27

3.94

36.6

25.9

30.42

30.37

0.74

3318

32410

(1761868) Lipid panel - Serum or Plasma

1001

11138

0.86

3.94

3.6

3.2

—

(3026361) Erythrocytes [#/volume] in Blood

3355

32804

1.27

3.93

36.7

26.0

4.40

4.45

e12/l

7.46

3287

31990

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

167

1221

1.39

3.89

2.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

151

2.13

3.89

1.4

1.6

2.18

7.95

nmol/l

1.13

125

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

151

2.13

3.89

1.1

—

(3010813) Leukocytes [#/volume] in Blood

3355

32808

1.27

3.89

36.8

26.1

7.02

6.82

e9/l

2.44

3284

31984

(3037756) Immunofixation for Serum or Plasma

114

778

1.48

3.87

1.5

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

892

0.58

3.87

1.1

0.52

0.63

ratio

—

113

(3000963) Hemoglobin [Mass/volume] in Blood

3355

32812

1.27

3.86

37.0

26.2

132.62

134.13

g/l

7.22

3319

32432

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

103

689

1.51

3.85

1.4

1.2

58.76

43.90

u/ml

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

307

1.77

3.85

1.5

1.3

6.34

6.98

g/l

0.63

222

(3024139) IgG subclass 3 [Mass/volume] in Serum

307

1.77

3.85

1.5

1.3

0.40

0.41

g/l

0.11

222

(3028192) IgG subclass 2 [Mass/volume] in Serum

307

1.77

3.85

1.5

1.3

2.78

2.95

g/l

0.30

221

(21494814) CD8 cells/Lymphocytes in Specimen

126

2.23

3.82

2.0

2.1

25.64

30.93

1.26

126

(4062490) Immunoglobulin typing, IgG

308

1.76

3.81

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

383

3146

1.24

3.81

2.2

2.1

0.04

0.01

estimate

0.29

652

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3064

29700

1.19

3.80

5.8

5.1

4.33

4.56

mmol/l

29.54

2859

27639

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

331

1.73

3.78

1.4

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

140

999

1.42

3.77

1.3

1.4

283.43

276.06

ug/g

0.16

594

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

957

0.60

3.73

1.2

1.52

1.54

g/l

0.19

957

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

138

985

1.42

3.71

1.5

0.10

8.05

iu/ml

0.67

191

(3049717) Cytology report of Urine Cyto stain

179

1335

1.36

3.71

2.5

2.7

—

(4024509) Urine culture

200

1521

1.33

3.65

2.0

1.9

—

(40768804) Tissue Pathology biopsy report

1390

12779

1.14

3.63

2.3

2.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

221

1709

1.31

3.59

2.3

2.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

415

1.63

3.52

2.1

1.5

0.24

0.34

nmol/l

1.65

317

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3109

30221

1.19

3.50

6.7

5.9

2.45

2.65

mmol/l

28.79

2898

28006

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

134

963

1.41

3.49

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

207

1.89

3.48

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.48

3.46

1.8

1.5

0.54

0.33

ug/l

0.54

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

152

2.05

3.45

1.0

1.1

1443.42

1523.59

miu/ml

0.15

152

(21494890) Protein electrophoresis panel - 24 hour Urine

371

1.66

3.45

1.5

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

111

774

1.45

3.42

3.9

3.4

0.93

0.83

nmol/l

0.54

615

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

619

1.50

3.39

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

209

1.88

3.39

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

160

2.01

3.39

2.5

2.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

958

8620

1.15

3.39

3.2

2.9

352.87

348.88

umol/l

0.50

811

7546

(3017143) Hepatitis C virus Ab [Presence] in Serum

396

3307

1.22

3.38

1.8

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.45

3.38

1.1

—

(3023419) Bacteria identified in Sputum by Culture

468

1.57

3.35

3.3

2.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

337

1.67

3.31

1.3

1.40

1.51

nmol/l

0.32

309

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.43

3.30

3.2

2.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

763

1.44

3.30

1.4

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3038

29509

1.17

3.27

5.7

5.1

1.41

1.45

mmol/l

5.51

2828

27271

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

773

1.44

3.27

1.3

1.1

2.25

4.47

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

157

2077

0.74

3.26

1.8

1.7

3.36

3.44

mmol/l

0.34

105

1454

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

647

5674

1.17

3.21

1.3

60.68

33.68

iu/ml

0.89

183

1730

(21494755) Public health laboratory ask at order entry panel

175

2274

0.76

3.20

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1383

12789

1.13

3.20

2.1

1.9

1.34

mmol/l

0.02

1186

10737

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.19

3.18

3.4

2.8

4.99

4.84

kpa

0.23

110

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.19

3.18

3.4

2.8

9.79

10.23

kpa

0.46

110

(3016228) CD19 cells/cells in Blood

130

2.08

3.17

1.9

2.0

8.22

8.70

0.12

122

(3037121) Protein [Mass/volume] in Urine

159

1196

1.34

3.16

3.5

3.2

352.06

318.47

mg/l

0.21

520

(3040151) Glucose [Moles/volume] in Capillary blood

397

1.60

3.13

4.9

5.4

6.80

7.29

mmol/l

0.75

339

(3008898) HLA-B27 [Presence]

129

942

1.38

3.10

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

624

1.47

3.09

1.6

1.4

—

20.69

—

(3016038) Potassium [Moles/volume] in Urine

231

1.78

3.07

1.7

1.2

34.01

35.69

mmol/l

0.17

202

(3017569) Oxygen content in Arterial blood

202

1.84

3.07

1.5

2.4

16.65

16.37

0.20

202

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

471

1.54

3.06

1.3

0.22

0.31

nmol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.69

3.05

1.3

2.0

—

7011.11

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

118

853

1.40

3.02

1.5

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

3.01

1.1

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

3.01

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

133

2.04

3.01

1.5

1.3

130.91

166.99

mmol/24h

1.98

133

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

554

1.49

3.00

1.6

1.5

148.37

152.66

au/ml

0.13

172

(3042631) Mycobacterium sp identified in Specimen

467

1.53

2.95

4.3

2.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1337

0.70

2.93

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

113

817

1.40

2.90

1.8

2.0

5.10

11.42

iu/l

0.40

316

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

108

2.14

2.90

1.1

1.2

0.31

0.30

g/l

0.27

(3008037) Lactate [Moles/volume] in Venous blood

120

877

1.38

2.89

3.8

3.1

1.57

1.64

mmol/l

0.48

115

849

(3024891) Influenza virus A+B Ag [Presence] in Specimen

107

767

1.41

2.89

1.2

—

(3045424) Erythrocytes [Presence] in Urine

200

1576

1.28

2.88

2.2

0.02

0.52

estimate

0.48

490

(3030981) Hyaline casts [#/volume] in Urine by Automated count

341

2854

1.21

2.88

3.2

2.5

0.38

0.49

e6/l

0.59

325

2738

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

116

844

1.39

2.87

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

124

913

1.37

2.86

1.5

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

423

1.55

2.85

1.8

2.3

0.93

1.38

g/24h

0.85

251

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

2.84

1.2

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

599

5276

1.16

2.81

1.3

6.65

12.27

u/ml

1.80

198

2024

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

2.81

1.3

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.65

2.79

1.0

1.4

4.04

604552.00

nmol/l

—

(3025941) Bacteria identified in Stool by Culture

207

1647

1.27

2.77

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

389

1.55

2.69

1.2

1.3

—

nmol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

175

1.84

2.68

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.13

2.64

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

375

1.56

2.64

1.6

2.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

237

1.70

2.57

1.1

1.4

9.01

9.33

mmol/l

0.19

230

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.36

2.55

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

135

1.93

2.55

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

135

1.93

2.55

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.43

2.53

1.3

—

(3036603) Volume of Urine

240

1.67

2.47

1.3

1.5

2012.10

1944.44

0.19

234

(3017509) Phencyclidine [Presence] in Urine

3.82

2.46

1.8

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

181

1.77

2.43

1.3

2.4

14.08

24.07

umol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.09

2.42

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

110

2.01

2.40

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

1.97

2.40

1.1

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

329

1.56

2.37

2.4

14.53

37.95

iu/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.42

2.36

1.1

1.4

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

4.12

2.36

1.6

1.2

43.57

49.10

—

(3024869) Neuronal Ab [Presence] in Serum

2.51

2.35

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

411

1.49

2.34

1.4

—

(3017732) Neutrophils [#/volume] in Blood

462

4053

1.16

2.30

3.3

3.4

4.45

4.83

e9/l

0.71

397

3486

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.62

2.27

1.8

4.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

208

1.69

2.26

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

106

1.99

2.25

1.8

2.0

2.16

1.64

ratio

0.82

(3003329) Lymphocytes/Leukocytes in Synovial fluid

286

1.58

2.25

1.6

1.5

32.52

29.51

0.19

177

(3017354) Segmented neutrophils/Leukocytes in Blood

358

1.52

2.24

2.8

3.5

57.30

57.02

0.03

307

(3024522) Salmonella sp identified in Specimen by Organism specific culture

407

1.48

2.24

1.4

—

(3000012) Reticulocyte production index

540

1.42

2.23

1.8

2.2

0.86

0.89

0.31

377

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

425

1.47

2.20

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

210

1.67

2.19

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

401

1.48

2.19

1.3

0.17

0.24

nmol/l

0.75

318

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

2.18

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

403

1.47

2.14

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

144

1.81

2.14

2.3

1.8

155.20

111.20

umol/l

0.26

(3004616) Nuclear Ab [Presence] in Serum

396

1.47

2.11

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

261

2204

1.20

2.07

1.5

1.4

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.01

2.07

3.8

2.2

249.20

160.80

ug/g

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

117

903

1.31

2.06

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

419

0.57

2.06

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

406

0.56

2.05

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

619

1.37

2.02

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.23

2.00

2.4

1.9

—

(3005033) Fetal Nuchal fold Thickness US

402

0.57

1.99

1.4

1.39

1.28

0.94

283

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

328

1.50

1.98

1.2

1.1

38.25

66.08

u/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

434

3837

1.15

1.96

5.4

5.0

33.10

32.65

0.39

339

2488

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.34

1.96

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.34

1.96

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

388

1.45

1.92

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

203

1.63

1.92

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

389

1.45

1.90

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

259

1.55

1.89

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

559

1.37

1.87

3.5

3.7

1.38

1.56

0.18

499

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

481

0.62

1.87

1.4

1.04

0.96

ratio

0.97

298

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

481

0.62

1.87

1.4

1.10

1.16

ratio

0.13

298

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

481

0.62

1.87

1.4

1.02

1.20

ratio

1.06

298

(3005988) Vibrio sp identified in Specimen by Organism specific culture

391

1.44

1.86

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

317

1.49

1.85

3.8

3.3

14.50

12.09

index

0.51

174

(3004716) Salmonella sp identified in Stool by Organism specific culture

170

1394

1.23

1.85

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.98

1.84

1.1

1.5

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.21

1.84

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

228

2687

0.84

1.84

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

359

1.45

1.83

1.8

1.4

26.15

26.91

u/l

0.05

296

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

478

0.62

1.83

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

477

4270

1.13

1.80

1.7

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.3

1.0

—

(3024932) HLA-DR beta [Type]

1.96

1.79

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

207

1.60

1.79

1.7

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

1.84

1.77

1.1

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

521

0.65

1.75

1.4

1.5

64.24

61.21

ug/l

0.12

433

(3024471) HLA-A [Type]

1.94

1.74

1.0

—

(3003694) ABO and Rh group [Type] in Blood

949

8855

1.10

1.68

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

211

1.57

1.67

1.9

2.1

7.46

8.27

mmol/l

0.87

211

(46235355) HIV 1 and 2 tests - Meaningful Use set

550

4993

1.12

1.66

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

334

1.44

1.65

1.1

—

(3044927) Protein electrophoresis panel - Urine

360

1.42

1.63

1.2

1.1

—

(21494434) Karyotype in Bone marrow

327

1.44

1.62

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

190

1.58

1.59

1.5

1.4

1.29

1.20

nmol/l

0.19

134

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

346

1.42

1.57

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

501

1.34

1.54

1.2

1.1

21.47

22.13

au/ml

—

107

(4133840) Spirometry

2.03

1.54

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

1.51

1.7

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

266

1.47

1.51

1.4

1.2

141.64

104.67

pmol/l

0.64

266

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

410

1.37

1.48

2.1

2.2

22.45

23.47

mg/l

0.06

145

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

377

3373

1.13

1.47

1.7

1.8

1.59

1.51

1.02

328

2951

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

232

2006

1.17

1.47

1.2

148.78

142.11

u/ml

0.09

731

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

268

1.46

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

156

1.61

1.43

1.2

1.3

190.36

377.66

u/l

1.04

142

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

632

1.29

1.41

1.1

1.2

36.95

36.73

u/l

0.00

546

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.42

1.39

2.0

1.1

—

(3035880) pH of Pleural fluid

206

1.51

1.37

1.2

1.4

7.38

7.41

0.25

140

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

323

1.40

1.35

1.2

56.48

66.06

u/l

0.70

283

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

120

1.67

1.34

3.1

2.8

0.58

0.61

mmol/l

0.88

120

(3036670) Protein [Mass/volume] in Synovial fluid

105

1.72

1.33

1.2

42.95

39.90

g/l

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

136

1.62

1.32

5.0

3.4

67.00

61.07

mg/l

0.12

100

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

617

6656

0.91

1.31

3.3

3.4

0.76

0.80

ug/l

0.28

438

4546

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

404

1.34

1.28

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.94

1.27

1.1

0.56

0.73

umol/24h

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

107

1.69

1.25

2.0

1.3

82.00

386.87

nmol/24h

0.60

107

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

901

0.78

1.25

1.4

1.6

981.13

1022.45

mu/l

0.16

744

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

253

1.43

1.24

1.3

1.2

121.25

140.61

titre

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.21

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

809

1.23

1.20

2.6

2.1

3977.89

5020.19

u/l

0.14

314

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

497

1.29

1.19

1.1

101.78

1293.20

iu/ml

0.49

103

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.31

1.18

1.5

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.88

1.18

1.2

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

173

1.51

1.17

1.7

1.29

3.42

u/field

1.20

126

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

1.16

0.0

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.05

1.15

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

1.15

0.0

12.8

—

0.20

—

(3019832) Treponema pallidum Ab [Presence] in Serum

259

2305

1.13

1.15

1.6

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

510

1.28

1.13

1.6

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.26

1.10

3.9

2.7

0.43

0.58

u/field

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

0.51

1.09

1.1

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

694

1.23

1.07

1.4

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.71

1.05

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

145

1250

1.17

1.03

1.3

1.7

0.32

0.33

mg/l

0.06

574

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2558

25081

1.07

1.03

31.7

22.1

331.67

331.92

g/l

0.70

2535

24922

(3006462) Nitrate [Presence] in Urine

146

1.51

1.03

2.6

3.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

196

1.43

1.02

1.6

1.5

8.45

7.00

u/l

0.17

157

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.84

0.98

11.4

13.7

5.08

5.80

mmol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.18

0.98

2.0

2.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.18

0.98

2.2

1.3

245.60

381.09

umol/24h

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1171

11232

1.06

0.97

5.4

5.8

3.53

3.46

ug/l

0.03

1055

10133

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

758

1.21

0.97

2.2

2.3

124.55

103.71

ug/min

0.27

457

(4211845) Urine protein measurement

157

1.47

0.96

2.6

3.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.69

0.95

1.4

2.5

437.69

403.39

ug/l

0.02

(3050129) First trimester maternal screen panel - Serum or Plasma

591

0.78

0.95

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

757

0.80

0.94

1.1

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

1.51

0.94

1.8

1.6

2.25

1.91

umol/l

0.88

119

(3032868) Hemoglobin electrophoresis panel in Blood

2.22

0.93

1.8

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.22

0.93

1.0

1.1

70.17

76.85

ug/l

—

(4146454) Self-monitoring of blood glucose

356

1.30

0.93

2.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

286

1.33

0.93

2.1

1.7

3.04

4.29

mg/l

2.94

279

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.14

0.91

1.0

1.2

7.17

14.43

u/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.63

0.90

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.75

0.90

2.6

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

438

0.75

0.88

1.4

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

1.52

0.88

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.72

0.86

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.94

0.84

3.2

1.2

—

(3012898) Urea [Moles/volume] in Urine

1.94

0.84

1.0

1.3

105.67

143.16

mmol/l

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.59

0.84

1.7

1.4

29.83

31.16

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

137

0.58

0.83

1.0

1.2

15.25

10.63

mm/h

—

137

(3016650) Hepatitis A virus Ab [Presence] in Serum

507

1.23

0.82

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.69

0.82

2.6

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.88

0.81

1.0

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.88

0.81

2.0

1.4

0.13

0.12

nmol/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

206

1.36

0.81

1.7

1.8

119.86

116.81

ng/l

0.06

206

(3035320) C reactive protein [Mass/volume] in Body fluid

247

0.69

0.79

3.4

2.6

27.45

32.69

mg/l

0.18

180

(1617658) Protocol used for examination of sentinel lymph nodes

235

0.68

0.79

1.1

—

(4212803) Bone marrow aspirate examination

1.77

0.76

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

270

1.30

0.76

1.1

1.2

301.54

355.24

nmol/l

0.91

233

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.08

0.74

5.0

4.0

2.23

2.09

mg/l

—

(3047189) Immunofixation for 24 hour Urine

175

1.37

0.74

1.3

1.6

—

(3016879) Cocaine [Presence] in Urine

819

1.16

0.73

1.6

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

117

1.46

0.71

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.75

0.71

1.1

1.2

—

640.53

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

805

0.84

0.71

1.4

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

2.2

1.2

—

(3019174) dRVVT (LA screen)

1.92

0.70

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.51

0.69

1.3

1.9

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.67

0.68

1.6

1.5

—

(3022621) pH of Urine by Test strip

281

2599

1.09

0.68

3.1

2.8

6.07

6.06

0.05

196

1812

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

213

1.32

0.68

1.1

13.08

9.27

iu/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

330

0.76

0.68

1.5

63.79

59.37

ug/l

0.22

330

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

294

1.26

0.66

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.59

0.65

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.73

0.64

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

766

1.15

0.63

1.1

8.06

5.84

eliau/ml

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.60

0.61

1.1

1.5

25.63

37.61

pmol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

137

1233

1.12

0.60

1.5

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

174

1.32

0.60

9.7

4.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

29.33

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

26.80

—

(3020874) Milk IgE Ab [Units/volume] in Serum

157

1.34

0.59

1.1

1.0

0.15

0.76

u/ml

—

(3002256) Pathology report gross observation

421

4448

0.94

0.58

1.4

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.72

0.57

1.2

1.60

1.82

umol/24h

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.72

0.57

1.0

1.1

0.02

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

700

0.85

0.56

4.4

3.5

19.99

28.03

mg/l

1.29

484

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

274

1.24

0.56

1.6

2.1

1.80

1.38

u/field

0.22

154

(40768793) Breast Pathology biopsy report

742

0.86

0.56

1.3

—

(3027944) Amphetamines [Presence] in Urine

879

1.13

0.55

1.6

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

178

1.29

0.53

1.3

1.4

183.57

210.93

pmol/l

0.19

178

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.50

0.51

1.2

11.02

8.42

mg/l

—

(3027008) Opiates [Presence] in Urine

885

1.12

0.51

1.6

2.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

324

1.21

0.50

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.50

1.2

1.0

—

(3022145) Colonoscopy Study observation

388

3684

1.06

0.50

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

156

0.70

0.49

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

167

0.72

0.49

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

167

0.72

0.49

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

167

0.72

0.49

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

167

0.72

0.49

1.5

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.52

0.48

1.7

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

528

0.85

0.48

1.6

1.7

—

(3028300) Cannabinoids [Presence] in Urine

890

1.12

0.47

1.6

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.49

0.47

1.0

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

541

1.15

0.47

2.1

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

200

1.25

0.46

2.0

1.5

84.04

83.88

umol/l

0.01

200

(3000764) Benzodiazepines [Presence] in Urine

883

1.11

0.46

1.6

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

534

1.14

0.45

1.4

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

247

1.22

0.44

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

238

1.22

0.44

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

396

1.16

0.42

1.0

1.1

11.30

2.25

u/ml

0.90

196

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

520

0.86

0.41

5.2

4.1

22.42

34.01

u/ml

1.44

505

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.38

0.41

1.3

1.1

35.01

40.88

iu/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

150

0.73

0.41

1.1

1.3

5.70

6.00

mmol/l

0.51

143

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

250

0.80

0.41

1.1

1.0

53.44

41.06

ng/l

0.74

171

(1761482) Bacteria [#/volume] in Urine by Culture

826

0.89

0.41

5.6

4.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

231

1.21

0.41

1.3

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.40

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

172

0.75

0.40

5.9

3.4

0.85

1.24

0.94

172

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.47

0.40

1.0

89.60

90.35

titre

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

132

1.29

0.40

2.2

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

249

0.80

0.40

1.1

1.0

700.93

301.38

ng/l

0.59

173

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

249

0.80

0.40

1.1

1.0

689.57

723.61

ng/l

0.11

168

(4281824) Cell count and differential, peritoneal fluid

336

0.83

0.40

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

36.28

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

237

0.80

0.39

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

316

1.17

0.38

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

142

1.27

0.38

1.2

1.0

12.92

0.43

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

866

1.10

0.38

1.7

5601.74

13518.39

e6/l

2.88

589

(3038177) Helicobacter pylori Ab [Presence] in Serum

451

0.86

0.37

1.4

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

120

1108

1.09

0.37

1.6

9.16

16.43

u/ml

1.44

237

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.35

0.37

2.8

1.5

1.39

1.38

umol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

417

0.86

0.35

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

0.66

0.35

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

171

1.23

0.35

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

410

4260

0.96

0.35

1.6

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

122

0.74

0.35

1.7

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

384

0.86

0.35

1.2

1.1

2.35

2.95

eliau/ml

0.19

168

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

804

1.10

0.35

1.2

1.3

172.63

224.05

miu/ml

0.82

367

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.36

0.34

1.0

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

1.1

0.00

0.17

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.36

0.34

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.36

0.34

1.0

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.34

0.34

2.7

1.7

—

(3005570) Glucose [Moles/volume] in Urine

340

0.85

0.34

2.3

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

445

1.13

0.32

1.1

—

(3020491) Glucose [Moles/volume] in Blood

229

1.18

0.32

1.6

2.0

7.55

6.57

mmol/l

0.57

155

(3001186) Copper [Moles/volume] in Serum or Plasma

1.31

0.31

1.1

1.2

17.32

16.83

umol/l

0.14

(3045142) Bone marrow Pathology biopsy report

408

1.13

0.31

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

933

0.92

0.30

1.4

—

(40757373) Influenza virus identified in Isolate

1.33

0.30

1.4

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

287

1.15

0.30

1.7

2.1

11.77

6.46

umol/l

0.49

200

(3010726) Horse dander IgE Ab [Units/volume] in Serum

451

1.11

0.27

1.1

2.13

1.47

u/ml

0.25

229

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

337

1.13

0.27

1.1

1.0

0.17

0.20

u/ml

0.11

117

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

121

0.74

0.27

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

121

0.74

0.27

1.7

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.21

0.26

1.0

1.3

—

(3016750) Collection duration of Urine

188

1.17

0.25

2.1

480.67

499.31

min

0.43

140

(3004775) Volume in Urine collected for unspecified duration

255

1.14

0.24

2.0

2.3

677.33

630.12

0.22

169

(3003740) Influenza virus B Ag [Presence] in Specimen

466

1.10

0.23

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

892

1.07

0.23

1.2

90.67

103.25

titre

0.24

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

257

1.13

0.22

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

362

1.11

0.22

1.1

11.80

3.84

u/ml

0.76

153

(3024263) Appearance of Synovial fluid

172

1.16

0.22

1.6

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

399

0.90

0.21

1.6

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

286

1.12

0.21

1.3

17.48

13.49

u/l

0.24

260

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

3.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

227.50

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.83

—

(3045788) Cell count panel - Pleural fluid

392

1.10

0.21

1.4

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

1.65

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.89

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.04

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.21

0.19

1.1

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.18

0.19

1.7

1.3

76.00

67.39

ug/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

361

3703

0.97

0.19

3.8

4.2

42.31

21.87

ug/l

0.36

300

3045

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

107

1018

1.05

0.18

1.7

3.58

4.68

mg/l

0.56

763

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

128

1.17

0.18

1.7

2.0

24.31

82.21

ug/l

0.47

116

(3033099) Centromere Ab [Titer] in Serum

1.15

0.17

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

466

1.07

0.16

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

751

0.94

0.16

3.5

3.4

1153.68

700.35

u/ml

0.16

695

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

149

1.14

0.15

1.2

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

872

0.95

0.15

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

154

1488

1.04

0.15

1.7

2.0

—

(4034850) Laboratory test

102

978

1.04

0.14

15.3

10.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

216

2102

1.03

0.14

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

181

0.88

0.14

1.2

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

562

0.94

0.13

1.1

2.00

2.17

u/ml

0.05

302

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.82

0.13

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.82

0.13

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.82

0.13

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.82

0.13

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.81

0.13

1.3

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

676

1.05

0.13

4.5

1.8

1.01

0.85

nmol/l

0.93

562

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

496

4883

1.02

0.13

1.7

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

325

1.08

0.13

1.5

1.4

253578.15

104552.83

e6/l

0.38

225

(3025130) Human papilloma virus identified in Specimen

407

0.93

0.13

1.6

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

806

1.04

0.12

1.3

1.2

—

(1002224) Polysomnography panel

133

1290

1.03

0.11

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

298

1.07

0.11

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

298

1.07

0.11

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

298

1.07

0.11

1.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

0.90

0.11

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

202

1.09

0.10

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

157

1532

1.03

0.10

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

359

1.06

0.09

3.2

3.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.05

0.08

2.8

1.5

0.50

0.47

e9/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.79

0.08

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

234

1.07

0.08

2.1

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.04

0.08

1.3

1.13

1.18

mmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

0.84

0.07

2.2

2.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.86

0.07

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

489

0.96

0.07

1.1

2.68

4.14

u/ml

0.42

250

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.83

0.07

1.4

1.5

—

0.31

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

157

1.08

0.07

2.4

2.1

23.71

130.18

ug/min

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.02

0.07

1.3

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.88

0.06

1.3

1.5

36.16

30.02

nmol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

236

1.06

0.06

1.4

1.2

0.77

1.59

u/ml

0.41

136

(3022689) Creatine [Moles/volume] in Urine

100

0.90

0.06

1.7

1.4

7.37

8.09

mmol/l

—

100

(3003434) Protein [Mass/volume] in Pleural fluid

542

1.03

0.06

1.5

29.88

31.81

g/l

0.53

489

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

148

1.08

0.06

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

287

1.05

0.05

1.3

1.5

—

(40765096) Chromosome analysis panel by Banding

110

0.91

0.05

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

477

1.03

0.04

1.5

1.4

1236.74

3707.63

e6/l

0.69

321

(44813793) Dust mix specific IgE antibody measurement

190

1.05

0.04

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

291

0.96

0.04

2.9

3.0

30.33

37.39

mg/l

0.17

223

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

518

1.02

0.03

1.0

1.1

—

(40768443) Skin Pathology biopsy report

144

1425

1.01

0.03

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

471

0.98

0.03

1.1

0.18

1.53

u/ml

2.87

203

(40768806) Pleura Pathology biopsy report

400

1.03

0.02

1.4

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

279

0.97

0.02

4.9

5.4

70.46

69.43

u/ml

—

(3012441) Differential panel - Pleural fluid

411

1.02

0.02

1.5

—

(40768441) Liver Pathology biopsy report

238

0.97

0.02

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

174

1752

0.99

0.02

4.1

3.4

1.02

ratio

0.18

160

1599

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

123

1.06

0.01

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

183

1.04

0.01

5.7

7.0

18.21

122.39

ug/l

—

116

(44806420) Estimation of glomerular filtration rate

327

0.98

0.01

2.6

2.5

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

146

0.96

0.00

1.5

1.6

58.57

66.50

—

119

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

274

1.02

0.00

1.2

—

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

145

0.97

0.00

1.4

1.7

41.39

39.53

g/l

0.89

145

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

185

0.97

0.00

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

185

0.97

0.00

1.2

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

233

2335

1.00

0.00

1.8

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

258

2575

1.00

0.00

1.9

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

903

9025

1.00

0.00

4.7

22.01

22.04

0.02

454

4645

(3020650) Glucose [Presence] in Urine

111

0.99

0.00

1.4

1.9

0.00

0.05

estimate

0.80

111

(3028308) Erythrocytes [#/volume] in Pleural fluid

416

1.01

0.00

1.6

1.4

86772.04

87464.69

e6/l

0.00

226

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

7.6

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1270.00

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.92

-0.00

1.1

1.4

13.65

8.60

ug/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

290.88

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

0.21

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

93.33

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

131

1310

1.00

-0.00

2.5

3.4

915.73

3572.38

u/ml

0.63

117

1132

(3051101) Glucose [Moles/volume] in Cord blood

0.89

-0.00

7.0

5.9

8.84

8.38

mmol/l

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.54

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3220.00

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

38.60

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.99

-0.00

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

3.0

—

(4015189) Microbial culture of sputum

0.96

-0.00

1.9

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_VISFIELDDEF and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_VISFIELDDEF	1.669 [1.52, 1.83]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.15

During the follow-up period (1.1.1998 — 31.12.2019), 2621 out of 10302 females with H7_VISFIELDDEF died.

Males

Parameter	HR [95% CI]	p-value
H7_VISFIELDDEF	1.77 [1.62, 1.94]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3731 out of 10733 males with H7_VISFIELDDEF died.

Mortality risk

Mortality risk for people of age

years, who have H7_VISFIELDDEF.

N-year risk	Females	Males
1	0.172%	0.307%
5	0.864%	1.93%
10	2.355%	4.547%
15	4.659%	8.466%
20	7.991%	14.145%

Relationships between endpoints

↥

Index endpoint: H7_VISFIELDDEF – Visual field defects

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Visual field defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints